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Progress in the understanding of the biology of perinatal tissues has contributed to the
breakthrough revelation of the therapeutic effects of perinatal derivatives (PnD), namely
birth-associated tissues, cells, and secreted factors. The significant knowledge acquired
in the past two decades, along with the increasing interest in perinatal derivatives, fuels
an urgent need for the precise identification of PnD and the establishment of updated
consensus criteria policies for their characterization. The aim of this review is not to
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go into detail on preclinical or clinical trials, but rather we address specific issues
that are relevant for the definition/characterization of perinatal cells, starting from an
understanding of the development of the human placenta, its structure, and the different
cell populations that can be isolated from the different perinatal tissues. We describe
where the cells are located within the placenta and their cell morphology and phenotype.
We also propose nomenclature for the cell populations and derivatives discussed herein.
This review is a joint effort from the COST SPRINT Action (CA17116), which broadly
aims at approaching consensus for different aspects of PnD research, such as providing
inputs for future standards for the processing and in vitro characterization and clinical
application of PnD.
Keywords: perinatal, derivatives, tissues, placenta, fetal annexes, cells, consensus nomenclature
INTRODUCTION
In the past 20 years, there have been significant advances in the
research and understanding of the biology of the placenta and its
derivatives. Initially, the placenta drew attention as an interesting
cell source due to its early embryological origin suggesting that
cells derived from the placenta could possess unique plasticity
and differentiation properties (Bailo et al., 2004). In addition,
the placenta displays favorable logistical issues, such as the fact
that the human term placenta is readily available at the time
of delivery.
We now know that perinatal derivatives are promising for
a wide range of regenerative medicine applications due to
their differentiation capabilities but mainly due to their unique
immune modulatory properties. As a matter of fact, many
preclinical studies and initial clinical trials have demonstrated
that perinatal derivatives may represent important tools for
restoring tissue damage or promoting regeneration and repair
of the tissue microenvironment (Caruso et al., 2012; Cirman
et al., 2014; Jerman et al., 2014; Silini et al., 2015; Joerger-
Messerli et al., 2016; Magatti et al., 2016; Couto et al., 2017;
Silini et al., 2017; Bollini et al., 2018; Pogozhykh et al., 2018;
Ramuta and Kreft, 2018; Verter et al., 2018; Silini et al., 2019;
Ramuta et al., 2020). The term “perinatal” refers to birth-
associated tissues that are obtained from term placentas and fetal
annexes and more specifically refers to the amniotic/amnionic
(herein referred to as amniotic due to its prevalence in literature)
membrane, chorionic membrane, chorionic villi, umbilical
cord (including Wharton’s jelly), the basal plate (including
maternal and fetal cells), and the amniotic fluid. The term
“derivatives” is used to refer to the cells isolated from placental
tissues, and the factors that these cells release, referred to
as their secretome or conditioned medium (including free
nucleic acids, soluble proteins, lipids, and extracellular vesicles
(such as exosomes, microvesicles and apoptotic bodies). Thus,
perinatal derivatives (PnD) include different birth-associated
tissues, the cells isolated thereof, and the factors secreted
by the cells [fractionated (free-floating factors, extracellular
vesicles, extracellular matrix components including proteins,
glycosaminoglycans, and glycoconjugates) and unfractionated
conditioned medium].
Over a decade ago, in 2008, the consensus from the First
International Workshop on Placenta-Derived Stem Cells was
published (Parolini et al., 2008). The consensus focused on
cells isolated from the amniotic and chorionic parts of the
fetal membranes and established the minimal criteria for the
definition of mesenchymal stromal cells (MSC) derived from
these membranes. In accordance to the criteria established for
other MSC sources (Dominici et al., 2006), the criteria established
at the First International Workshop on Placenta-Derived Stem
Cells focused on adherence to plastic, formation of fibroblast-
like colony-forming units, differentiation potential toward one or
more lineages, including osteogenic, adipogenic, or chondrogenic
lineages, and specific cell surface antigen expression from in vitro
passages 2 to 4 (Parolini et al., 2008). In addition, the criteria
included one other specific aspect, the determination of the fetal
or maternal origin of the perinatal cells (Parolini et al., 2008).
During the last two decades, the literature published on
perinatal derivatives has grown exponentially. Specific cells such
as MSC have been isolated and characterized from different
perinatal tissues, such as the fetal membranes (In ’t Anker et al.,
2004; Soncini et al., 2007; Wolbank et al., 2010), chorionic villi
(Fukuchi et al., 2004; Igura et al., 2004; Portmann-Lanz et al.,
2006; Castrechini et al., 2010), decidua (In ’t Anker et al., 2004;
Araújo et al., 2018; Ringden et al., 2018; Guan et al., 2019), and
umbilical cord (Wang et al., 2004b; Troyer and Weiss, 2008; La
Rocca et al., 2009; Hartmann et al., 2010).
The significant increase in acquired knowledge has been
paralleled with the evident need for the establishment of updated
criteria and consensus policies for the characterization of PnD.
Thus, this review aims at providing an updated and extended
consensus starting from the policies published in 2008, which
were specifically related to cells from fetal membranes (Parolini
et al., 2008), and at addressing specific issues related to the proper
and transparent definition of PnD, relating not only to fetal
membranes but also to all other regions and perinatal tissues.
One issue that must be addressed is related to defining
PnD. In its simplest form, this means establishing a reference
nomenclature for each derivative that can be isolated from all
perinatal, birth-associated tissues. Birth associated or perinatal
tissues and organs, such as the human placenta, are complex and
are comprised of different tissues (as mentioned above, amniotic
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FIGURE 1 | Architecture of the human term placenta. General overview of the relationship between the basal decidua (maternal side/component of the human
placenta) and the fetal side/component of the human placenta represented by the chorion frondosum, the chorionic plate and the fused amniotic membrane
(placental portion). The residual portion of the amniotic membrane (reflected portion) adheres to the chorion laeve (so called because it is devoid of villi) which is in
touch with the capsular decidua. The amniotic membrane surrounds the amniotic cavity containing amniotic fluid with different types of detached cells. The
magnified scheme shows the different parts of the term placental architecture. hBD-MSC, human basal decidua-mesenchymal stromal cells; hAFC, human amniotic
fluid cells; hAFSC, human amniotic fluid stem cells; hAF-MSC, human amniotic fluid-mesenchymal stromal cells.
membrane, chorionic membrane, chorionic villi, umbilical cord,
basal plate including fetal trophoblast cells and maternal uterine
cells, and amniotic fluid) (Figure 1). Even today, there is
much confusion regarding the identification and location of
the specific perinatal tissues and cells. In the current literature
the nomenclature used does not necessarily highlight the true
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differences between cells. At the same time, not all cells can
simply be referred to as “placenta-derived stem cells” (Oliveira
and Barreto-Filho, 2015), without taking into consideration the
exact tissue from which they were derived. A proper and clearly
defined nomenclature is absolutely necessary to understand
which cells are isolated and used in cell cultures. Incorrect
nomenclature and definition of cells ultimately impact the correct
identification of the cells and/or derivatives obtained and hinder
the direct comparison of results among different research groups.
Reference nomenclature should be established followed by a
clear indication of the precise localization of cells in perinatal
tissues. This should be followed by the next crucial step,
the definition of the phenotype of cells and more specifically
the markers that will serve as reference standards to identify
specific cell types. To this regard, it is important to consider
an aspect specifically related to perinatal cells and that is the
determination of the fetal or maternal origin (Parolini et al.,
2008). This is critical since the detection of maternal cells may
depend on cell expansion in in vitro culture. For example,
we previously demonstrated that genomic Polymerase Chain
Reaction amplification was not able to determine the presence
of maternal cells in the freshly isolated mesenchymal fractions
of both the amnion and chorion (Soncini et al., 2007). However,
after several cell passages in culture, maternal cells were detected
in cell populations from the chorionic membrane, while those
from the amniotic membrane did not show the presence of
maternal alleles (Soncini et al., 2007). Hence, this may well result
in working with a mixture of maternal and fetal cells, while the
intent was to just work with fetal cells.
Another important aspect relates to cell culture expansion,
because specific characteristics of the cells change, including
phenotype and expression of specific proteins. This may result
in the impression that one may be working with different
cells compared to those isolated from perinatal tissues. In the
case of human amniotic membrane MSC (hAMSC) and human
amniotic membrane epithelial cells (hAEC) from placenta, it has
previously been demonstrated that cell culture up to passage 4
after isolation (passage 0) can induce changes in the expression
of cell markers. Such changes include the significant increase
in adhesion molecules (e.g., CD49b, CD49d) and the significant
decrease of CD14, CD45, and HLA-DR expression on hAMSC,
as well as the significant increase of CD13, CD44, CD105,
CD146 expression on cultures of hAEC (Stadler et al., 2008;
Magatti et al., 2015).
Here, considering the numerous publications and the
increasing interest in perinatal derivatives, we address
specific issues that are relevant for the clear and precise
definition/characterization of perinatal cells, starting from an
understanding of the development of the human placenta,
its structure, and the different cell populations that can be
isolated from the different perinatal tissues. In addition, we
describe where the cells are located within the placenta and
provide an atlas of the human placenta. We also describe cell
morphology and phenotype and propose nomenclature for the
cell populations and derivatives discussed herein. The proposed
nomenclature will be crucial to lay the foundation for the
consistency in the scientific community when referring to PnD.
This review is a joint effort from the COST SPRINT Action
(CA17116), which broadly aims at approaching consensus for
different aspects of PnD research, such as providing inputs for
future standards for the processing, in vitro characterization and
clinical application of PnD.
DEVELOPMENT OF THE HUMAN
PLACENTA
The placenta is the first organ to develop in mammals. It
is essential for the successful growth of the embryo, and
later the fetus, and its crosstalk with the uterine maternal
compartment is indispensable. Its fundamental role is underlined
by the fact that impaired formation of placental tissues leads
to pregnancy disorders, such as preeclampsia, fetal growth
restriction, recurrent miscarriage, and stillbirth. The embryo-
maternal interface is based on an intimate and controlled
relationship between the conceptus and the mother. The
placenta and extraembryonic membranes maintain this essential
contact for supporting the development of the new organism
by acquiring oxygen and nutrients, eliminating waste, and
avoiding immune rejection. However, despite its importance in
reproductive outcome, there is still a limited understanding about
human placental development, mainly due to ethical and logistic
difficulties in investigating it in the early stages, as well as in
extrapolating data from other species (Enders and Carter, 2004;
Turco and Moffett, 2019).
The development of the human placenta begins from the
first days after conception (Figure 2). Fertilization takes place
in the ampulla, the third portion of the uterine tube, and
consists of the fusion of the female gamete, the egg, with the
male gamete, the sperm. After the formation of the zygote at
fertilization, the subsequent cleavage phase leads to a series of
mitotic divisions which give rise to the formation of a compact
mass, the morula (early and late stage), and subsequently to
the blastocyst consisting of a single layered epithelial cover,
called trophoblast or trophectoderm, which surrounds and
encloses the cavity of the blastocyst (blastocoel). Inside this
cavity there is a group of concentrated and polarized cells
that constitute the inner cell mass (ICM), the embryoblast
(Figure 2A). Following blastocyst formation implantation takes
place in the uterine wall 6-7 days after fertilization. At the
time of blastocyst attachment, trophoblast/trophectoderm cells in
direct contact with the endometrial epithelium start to fuse and
generate the first trophoblast cell type, the syncytiotrophoblast.
Apparently, only this multinucleated structure is able to penetrate
through the endometrial epithelium. The syncytiotrophoblast
and the underlying layers of mononucleated cytotrophoblasts still
surround the ICM, which is committed to create all embryonic
tissues, the umbilical cord and the epithelium of the amniotic
membrane. Following implantation, the ICM gets surrounded by
a ball-shaped placenta (Figure 2B). This is the prelacunar phase
of placental development (Benirschke et al., 2006).
As shown in Figure 2, at this early stage of development (day
6-7) the trophoblast/trophectoderm does not directly contribute
to the development of the embryo but constitutes the fetal
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FIGURE 2 | Stages of placental development. (A) Implantation at 6 to 7 days (d) after conception; (B) prelacunar period (7 to 8 days); (C) beginning of lacunar period
(8 to 9 days); (D) transition from lacunar period to primary villus stage (12 to 15 days); (E) secondary villus stage (15 to 21 days); and (F) tertiary villus stage (18 days
to week 12). BP, basal plate; BV, blood vessel; CP, primary chorionic plate; CT, cytotrophoblast; D, decidua; E, endometrial epithelium; EB, embryoblast; EG,
endometrial gland; EM, extraembryonic mesoderm; EVT, extravillous trophoblast; IVS, intervillous space; M, myometrium; NF, Nitabuch fibrinoid; PB, placental bed;
RF, Rohr fibrinoid; SA, spinal artery; ST, syncytiotrophoblast; T, trabeculae; TS, trophoblastic shell; UV, umbilical vein. (Redrawn and modified from Kaufmann, 1981).
portion of the placenta: the chorion. In this phase, the cells
of the ICM differentiate into two layers: the hypoblast, or
primitive endoderm, a layer of small cubic cells facing the
blastocoel cavity, and the epiblast, or primitive ectoderm, a layer
of cylindrical cells facing the embryonic pole and adjacent to
what will become the amniotic cavity. Together these two cell
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layers form the bilaminar embryonic disk. At the 8th day post
conception, some cells from the epiblast migrate and position
between the cytotrophoblast and the underlying embryonic disk,
creating a small space that will later become the amniotic
cavity. The cells derived from the epiblast, which surround the
future amniotic cavity, are called amnioblasts and will give rise
to the amniotic epithelium. Subsequently, the cytotrophoblast
secretes a spongy layer of acellular material, called the
extraembryonic reticulum, which will give rise to extraembryonic
mesoderm after invasion of the migratory cells from the epiblast.
This layer surrounds the yolk sac and the amniotic cavity
and, subsequently, will constitute the amniotic and chorionic
mesoderm (extraembryonic somatopleuric mesoderm). At this
point fluid-filled spaces (lacunae) begin to develop within the
syncytial mass that enlarge and merge leading to the formation of
a lacunar system (lacunar stage) (Figure 2C). As a consequence
of the erosion of the endothelial lining of the maternal capillaries,
lacunae are filled with maternal blood giving rise to a primitive
filling of the lacunae with maternal blood, while a utero-placental
circulation will only develop later in pregnancy. At day 13 post
conception (Figure 2D) the cytotrophoblasts proliferate locally
and penetrate the syncytiotrophoblast forming columns of cells
surrounded by the syncytium, the primary villi. Subsequently,
cells of the extraembryonic somatopleuric mesoderm penetrate
inside the primary villi and grow in the direction of the
decidua, i.e. the maternal component of the placenta, to form
the secondary villi (Figure 2E). From the end of the third
week (Figure 2F), the mesodermal cells inside the villi begin
to differentiate into endothelial and blood cells and thus form
small blood vessels that give rise to the capillary system of
the villi and to the tertiary or definitive villi. The villous
cytotrophoblast progressively penetrates the syncytiotrophoblast
until they reach the endometrium to form trophoblastic cell
columns and the external cytotrophoblastic shell. At the point
where the cytotrophoblast is in touch with the maternal decidua,
single cytotrophoblast cells leave the shell to invade into the
decidua as extravillous trophoblast (EVT) in a process closely
resembling epithelial-mesenchymal transition (EMT). During
the second month of pregnancy, due to the increased volume
of the amnion, the amniotic membrane fuses with the chorion
leading to the formation of the amnio-chorionic membrane.
Within the first trimester of pregnancy the organization and
structure of the placenta is established.
STRUCTURE OF THE EARLY PLACENTA
During the first trimester of pregnancy, the placenta develops all
the structures needed for a sufficient supply of nutrients to the
embryo and, subsequently, the fetus during pregnancy (Huppertz
et al., 2014). Several structures can be identified in a first trimester
placenta (from embryo to mother) (Figure 3), at which time, the
amnion is not fully developed, hence a specific layer of amniotic
membrane cannot be found covering the chorionic plate at this
stage of pregnancy. The first layer of a first trimester placenta
from the embryo’s perspective is the chorionic mesenchyme,
a vascularized connective tissue where the connecting vessels
between placental villi and connecting stalk (that later develops
into the umbilical cord) can be found. As placental villi grow
from the side of the chorionic layer facing the intervillous space,
it is referred to as chorionic plate of the placenta (Figure 3A).
At the side towards the intervillous space, the chorionic plate
is still covered with the same layers as the placental villi,
syncytiotrophoblast and villous cytotrophoblast (Figure 3A).
From the chorionic plate, larger villi grow into the intervillous
space (Figure 3A) and form tree-like structures, the villous
trees. Longitudinal growth in combination with branching and
sprouting generates these tree-like structures (Figure 3). During
the first trimester of pregnancy, until week 12 to week 14, there
is no flow of maternal blood through the intervillous space
surrounding the placental villi.
The placental villi are covered by the syncytiotrophoblast that
comes in direct contact with maternal plasma/blood. Directly
underneath the syncytiotrophoblast, a complete layer of villous
cytotrophoblast can be found (Figure 3B). These cells represent
the proliferating progenitor cells of this epithelial layer. Some
of the progenitors’ sibling cells differentiate and fuse with the
overlying syncytiotrophoblast. Connective tissue derived from
the chorionic mesenchyme fills the cores of the placental villi.
Within this tissue, blood vessels, blood cells as well as placental
macrophages (Hofbauer cells) (Figure 3B) develop prior to the
connection to the embryonic blood system via the connecting
stalk (Huppertz and Peeters, 2005; Demir et al., 2007).
During the first half of the first trimester of pregnancy,
the freely floating villi are very primitive and are classified as
mesenchymal villi. At about 8 to 10 weeks of pregnancy, the first
mesenchymal villi differentiate into immature intermediate villi,
characterized by stromal channels where placental macrophages
can easily be visualized. The placental villi that connect to
the uterine wall are called anchoring villi (Figure 3C). This
is the site where the placenta is anchored to the uterine wall
and where trophoblastic cell columns (Figure 3C) are formed
as sources for all extravillous trophoblast cells invading into
the decidua and the inner third of the myometrium of the
placental bed (interstitial trophoblast) (Figure 3D). From the
interstitial trophoblast (Figures 3C,D) a variety of other subtypes
of extravillous trophoblast develop to allow proper nutritional
support of the embryo and fetus throughout pregnancy. The
trophoblast invades into the uterine spiral arteries (endoarterial
trophoblast), the uterine veins (endovenous trophoblast), the
uterine glands (endoglandular trophoblast), and finally into the
uterine lymph vessels (endolymphatic trophoblast) (Figure 3)
(Moser et al., 2018b). The endoarterial trophoblast blocks the
flow of maternal blood into the intervillous space and only
blood plasma is able to pass through these trophoblast plugs
(Figure 3: dashed red arrow in the invaded artery) and reaches
the placenta. Additionally, due to invasion by endoglandular
trophoblast, secretion products of uterine glands flow into the
intervillous space as well (Figure 3: green arrow in the invaded
gland). All of this is transferred back into the maternal system
by utero-placental veins (Figure 3: green arrow and dashed red
arrow in invaded vein), connected to the placenta by invasion
of endovenous trophoblast (Figure 3) (Moser et al., 2018b;
Huppertz, 2019).
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FIGURE 3 | Schematic representation of a human placenta during the first trimester of pregnancy. The chorionic plate represents the embryonic side of the placenta
from which placental villi grow into the intervillous space. Anchoring villi are connected to the uterine wall by trophoblast cell columns from which extravillous
trophoblasts invade into uterine tissues. From these sites interstitial trophoblast invades into the uterine stroma, differentiating into endoglandular trophoblast
invading uterine glands, endovenous trophoblast, invading uterine veins and endoarterial trophoblast invading into uterine spiral arteries Histological images of (A)
first trimester chorionic plate with a placental villus extending into the intervillous space, (B) first trimester mesenchymal villus with the cover of villous trophoblast and
the mesenchymal villous stroma, (C) anchoring villus that is attached to the uterine wall by a trophoblast cell column, (D) first trimester placenta showing a number of
anchoring villi attached to the uterine wall by trophoblast cell columns. Within the uterine wall a huge amount of interstitial trophoblast invades towards vessels,
glands and the myometrium. A, uterine spiral artery; AV, anchoring villus; CC, trophoblast cell column; CP, chorionic plate; G, uterine gland; GA, gestational age; IT,
interstitial trophoblast; IVS, intervillous space; PM, placental macrophage (Hofbauer cell); PV, placental villus; STB, syncytiotrophoblast; V, uterine vein; VCTB, villous
cytotrophoblast; VS, villous stroma.
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FIGURE 4 | Schematic representation of a human placenta at term. The amniotic membrane is the layer closest to the fetus and is attached to the chorionic plate
mesenchyme from which large stem villi reach into the intervillous space. The villous trees are fully differentiated and have a large number of terminal villi where
enlarged capillaries, sinusoids, allow a higher exchange rate between maternal and fetal blood. Anchoring villi are still connected to the uterine wall, while trophoblast
cell columns are exhausted. Spiral arteries invaded by endoarterial trophoblast and uterine veins invaded by endovenous trophoblast can still be found in the
placental bed allowing the constant flow of maternal blood into the placenta and the drainage back into the maternal circulation (red arrows in artery and vein).
Histological images of (A) term amniotic membrane with epithelium and avascular mesenchyme, (B) term chorionic plate covered by the amniotic membrane, (C)
placental villi of a term placenta with a sinusoid in a terminal villus and a neighboring mature intermediate villus, (D) anchoring villus that is attached to the uterine wall
where interstitial trophoblast can be found, (E) vessel in the basal plate of a term placenta. The vessel is surrounded by interstitial trophoblast. A, uterine spiral artery;
AM, amniotic membrane; AV, anchoring villus; CP, chorionic plate; GA, gestational age; IT, interstitial trophoblast; MIV, mature intermediate villus; SI, sinusoid; STB,
syncytiotrophoblast; TV, terminal villus; V, uterine vein.
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STRUCTURE OF THE TERM PLACENTA
At the end of pregnancy, the placenta has all the structures
that were needed to supply the fetus with sufficient amounts of
nutrients and gases, as well as to allow excretion of waste products
(Huppertz, 2008). In the term placenta, the following structures
are present (from fetus to mother) as shown in Figure 4.
The fetus bathes in the amniotic fluid. The outer border of
the fluid-filled cavity is demarcated by the amniotic epithelium,
a cuboidal and mostly single layered epithelium (Figures 4A,B).
Under the basement membrane, the amniotic mesenchyme can
be found, an avascular connective tissue. Amniotic epithelium
and mesenchyme form the amnion, which surrounds the
embryo (Figure 4B).
The next layer is the chorionic mesenchyme. This connective
tissue is vascularized and contains the vessels between placental
villi and umbilical cord. At the site of the decidua basalis,
this layer is called chorionic plate (Figure 4B), while at the
site of the fetal membranes it is referred to as chorionic layer
of the fetal membranes, the chorion laeve. At the surface
of the chorionic plate towards the intervillous space of the
placenta, some remnants of extravillous trophoblast may be
found (Figure 4). From the chorionic plate, large stem villi reach
into the intervillous space and are the trunks of the tree-like
structures, the villous trees giving rise to the chorion frondosum.
In a term placenta, differentiation of the villous structure leads to
a completely different set of villi compared to the first trimester
of pregnancy. At term, most of the villi (40%) are terminal
villi that are the site of direct transfer of nutrients and gasses
between maternal and fetal blood (Figure 4C). Terminal villi
can be seen as leaves of a tree, while the underlying mature
intermediate villi (Figure 4C) are the connecting branches of
the tree, making up about 25% of the total villous volume at
term. The placental villi are covered by the syncytiotrophoblast
that comes in direct contact to maternal blood and releases
huge amounts of fetal material into the maternal circulation
(Huppertz et al., 1998). Due to the huge expansion of the villous
stroma, the syncytiotrophoblast at term is much thinner than
in the first trimester. Also, the layer of villous cytotrophoblast
has become discontinuous and only occasionally, single villous
cytotrophoblast cells can be identified (Figure 4). The villous
stroma is fully differentiated with large caliber arteries and veins
in stem villi and sinusoids, enlarged capillaries, in the terminal
villi (Figure 4C). Placental macrophages, Hofbauer cells, are
present in each and every villus of the placenta.
At term, the anchoring villi are still attached to the uterine
wall (Figure 4D). However, the trophoblast cell columns are
exhausted and no longer present as real columns (Figure 4D).
Interstitial trophoblast can be found in the basal plate of the
placenta (Figure 4D) as well as in the placental bed surrounding
luminal structures like arteries and veins (Figure 4E).
At the end of pregnancy, trophoblast that has invaded into
uterine spiral arteries (endoarterial trophoblast) and utero-
placental veins (endovenous trophoblast) can still be found.
Invaded endometrial glands are hardly visible at term. In
addition, at term the endoarterial trophoblast has led to a
widening of uterine spiral arteries to allow a constant flow
of maternal blood into the intervillous space (Figure 4: red
arrow in the invaded artery) (Huppertz, 2019). Maternal blood
is drained back into the maternal circulation by utero-placental
veins (Figure 4: red arrow in invaded vein), connected to the
placenta by invasion of endovenous trophoblast (Figure 4).
CELLS ISOLATED FROM THE TERM
PLACENTA AND FETAL ANNEXES
Human Placenta Cells (hPC)
Several cell types can be obtained and expanded from the
different regions of the human placenta and the fetal annexes.
Human placenta cells (hPC) is a generic term used to refer to
any type of cell that can be isolated from term placenta; the
most prominent being epithelial cells, mesenchymal stromal cells
(MSC), endothelial, and hematopoietic cells.
Amongst these, human placenta MSC (hPMSC) is a general
term commonly used to refer to MSC from various perinatal
tissues. hPMSC from the different tissues described herein
possess similar characteristics in accordance with the minimal
consensus criteria reported for MSC from other adult tissues,
such as bone marrow (Dominici et al., 2006) and established also
for placenta-derived cells during the First International Workshop
on Placenta-Derived Stem Cells held in Brescia, Italy in 2007.
This includes the expression of CD90, CD73, and CD105, and
the lack of expression of CD45, CD34, CD14, and HLA-DR
(Parolini et al., 2008).
In order to advise the scientific community on the precise
localization and nomenclature of perinatal tissues and cells, in
the following paragraphs the main characteristics of the different
placental/perinatal regions/tissues, and features of their cells will
be described. To discriminate similar cells of different origins
more accurately a nomenclature will be proposed (Table 1). We
also provide representative figures for several cell populations in
order to illustrate their localization within given placental sites.
Human Amnio-Chorionic Membrane
(hACM) and Human Amniotic Membrane
(hAM)
The human amniotic membrane (hAM) represents the wall of
an embryo/fetal annex called the amnion or amniotic sac, which
encloses the amniotic cavity and contains the amniotic fluid (AF),
(Figure 5). During embryonic development, the enlargement of
the amniotic cavity causes the hAM to come in contact with
the chorion leading to the formation of the amnio-chorionic
membrane (hACM), which is the membrane of the human
placenta directly facing the embryo/fetus. It is the general term
for the combination of the fetal part of the fetal membranes plus
the chorionic plate. Cells isolated from this membrane can be
generally referred to as human amnio-chorionic membrane cells
(hACMC). The phenotype of hACMC depends on the specific cell
type (i.e. epithelial, mesenchymal) and is consistent with those
described below.
The hAM is a monolayer of cuboidal-shaped human amniotic
membrane epithelial cells (hAEC) with microvilli on the apical
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human placenta cells hPC
human placenta mesenchymal stromal cells hPMSC
human amnio-chorionic membrane hACM
human amnio-chorionic membrane cells hACMC
human amniotic membrane hAM
human amniotic membrane cells hAMC
human amniotic membrane epithelial cells hAEC
human amniotic membrane mesenchymal stromal cells hAMSC
human placental amniotic membrane hPAM
human placental amniotic membrane cells hPAMC
human placental amniotic membrane epithelial cells hPAEC
human placental amniotic membrane mesenchymal
stromal cells
hPAMSC
human reflected amniotic membrane hRAM
human reflected amniotic membrane cells hRAMC
human reflected amniotic membrane epithelial cells hRAEC
human reflected amniotic membrane mesenchymal
stromal cells
hRAMSC
human chorion (chorionic membrane) hCM
human chorionic membrane cells hCMC





human villous cytotrophoblast hVCTB
human extravillous trophoblast hEVT
human proximal cell column trophoblast hpCCT
human distal cell column trophoblast hdCCT
human interstitial extravillous trophoblast hiEVT
human endovascular extravillous trophoblast hvasEVT
human endoarterial extravillous trophoblast hartEVT
human endovenous extravillous trophoblast hvenEVT
human endoglandular extravillous trophoblast hglaEVT
human endolymphatic extravillous trophoblast hlymEVT
human trophoblast stem cells hTSC
human trophoblast progenitor cells hTPC
human chorionic plate hCP
human chorionic plate cells hCPC
human chorionic plate mesenchymal stromal cells hCP-MSC
human chorionic plate mesenchymal stromal cells
derived from blood vessels
hCP-MSC-bv
human chorionic plate extravillous trophoblast hCP-EVT
human chorionic villi (chorion frondosum) hCV
human chorionic villi cells hCVC
human chorionic villi mesenchymal stromal cells hCV-MSC
human chorionic villi trophoblast cells hCV-TC
human chorion laeve hCL
human chorion laeve mesenchymal stromal cells hCL-MSC
human chorion laeve extravillous trophoblast hCL-EVT
human umbilical cord hUC
human umbilical cord cells hUCC
(Continued)
TABLE 1 | Continued
Name Consensus
Abbreviation
human umbilical cord mesenchymal stromal cells hUC-MSC
human umbilical cord amniotic membrane hUC-AM
human umbilical cord amniotic membrane cells hUC-AMC
human umbilical cord amniotic epithelial cells hUC-AEC
human umbilical cord amniotic mesenchymal stromal cells hUC-AMSC
human umbilical cord Wharton’s jelly hUC-WJ
human umbilical cord Wharton’s jelly cells hUC-WJC
human umbilical cord Wharton’s jelly mesenchymal stromal
cells
hUC-WJ-MSC




human umbilical cord intermediate Wharton’s jelly
mesenchymal stromal cells
hUC-iWJ-MSC
human umbilical cord vascular region hUC-V
human umbilical cord perivascular cells hUC-PVC
human umbilical cord vascular smooth muscle cells hUC-VSMC
human umbilical cord myofibroblasts hUC-MF
human umbilical vein endothelial cells HUVEC
human umbilical artery endothelial cells HUAEC
human placental endothelial cells hP-EC
human chorionic villi endothelial cells hCV-EC
human placenta microvascular endothelial cells hP-mV-EC
human chorionic plate endothelial cells hCP-EC
human placental venous endothelial cells (derived from
chorionic veins)
hPV-EC
human placental arterial endothelial cells (derived from
chorionic arteries)
hPA-EC
human amniotic fluid hAF
human amniotic fluid cells hAFC
human amniotic fluid stem cells hAFSC
human amniotic fluid mesenchymal stromal cells hAF-MSC
human decidua hD
human decidual stromal cells hDSC
human decidua predecidual stromal cells hD-preDSC
human decidua decidualized stromal cells hD-dDSC
precursors of decidualized stromal cells preDSC
human decidua mesenchymal stromal cells hDMSC
human basal decidua hBD
human basal decidua predecidual stromal cells hBD-preDSC
human basal decidua decidualized stromal cells hBD-dDSC
human basal decidua mesenchymal stromal cells hBD-MSC
human parietal decidua hPD
human parietal decidua predecidual stromal cells hPD-preDSC
human parietal decidua decidualized stromal cells hPD-dDSC
human parietal decidua mesenchymal stromal cells hPD-MSC
human capsular decidua hCD
human capsular decidua predecidual stromal cells hCD-preDSC
Bold text is used to identify perinatal tissues and to distinguish them from cell
populations. See text for more details on the cell types.
surface in direct contact with the AF (Figure 5). An in situ
investigation revealed the morphological heterogeneity of the
different cell populations belonging to different regions identified
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within the hAM (Centurione et al., 2018). This heterogeneity
could be due to the fact that the majority of research laboratories
use the hAM that adheres to the chorion laeve (i.e. human
reflected amniotic membrane, hRAM), rather than hAM that
adheres to the chorionic plate (i.e. human placental amniotic
membrane, hPAM). As a matter of fact, Centurione et al.,
identified four areas of the hAM: the central, intermediate,
peripheral, and reflected regions in relation to the umbilical cord
(Centurione et al., 2018). Interestingly, the epithelial layer was
found to be multilayered in all areas except in the intermediate
area, while in the central area the nuclei were located in a higher
position compared to the other regions. Furthermore, apoptotic
cells were predominantly found in the central area, although, in
other areas, budding and detaching cells were present as well.
Human Amniotic Membrane Cells (hAMC)
Human amniotic membrane cells (hAMC) are of fetal origin.
The structure of the hAM defines a layer of hAEC in
direct contact with the AF and a population of amniotic
membrane mesenchymal stromal cells (hAMSC) embedded in
the underlying connective tissue (Figure 5). In addition, the
location of the hAM relative to the chorionic regions (chorionic
plate and chorion laeve) determines at least two populations of
hAMC, human reflected amniotic membrane cells (hRAMC) and
human placental amniotic membrane cells (hPAMC).
Amniotic cells can be isolated from the hAM either as a
heterogenous total population or by separate enzymatic digest
to obtain hAEC and hAMSC. In most protocols trypsin is used
for isolation of hAEC and collagenase for hAMSC (Casey and
MacDonald, 1997; Whittle et al., 2000; In ’t Anker et al., 2004;
Sakuragawa et al., 2004; Miki and Strom, 2006; Portmann-Lanz
et al., 2006; Soncini et al., 2007; Sudo et al., 2007; Tamagawa et al.,
2007; Wolbank et al., 2007; Bilic et al., 2008; Magatti et al., 2008;
Parolini et al., 2008; Wei et al., 2009; Kang et al., 2012; Lindenmair
et al., 2012; Lisi et al., 2012). However, other digestive enzymes
including dispase (Soncini et al., 2007; Tamagawa et al., 2007; Bilic
et al., 2008; Díaz-Prado et al., 2010) or enzyme combinations (e.g.,
collagenase/DNase) (Alviano et al., 2007; Soncini et al., 2007;
Konig et al., 2012) have also been utilized.
The quality of amniotic cells mostly depends on expansion
conditions rather than isolation methods. They can be expanded
using standard culture media composed of a basal medium,
supplemented with serum, antibiotics and antimycotics. Some
groups use additional supplements including epidermal growth
factor (EGF) (Miki et al., 2007; Stadler et al., 2008; Niknejad
et al., 2012; Miki et al., 2016) or specific commercial media like
endothelial growth medium-2 (Stadler et al., 2008). Although
fetal bovine serum (FBS) remains the gold standard in hAMC
cultures, efforts have been made to substitute FBS by human
alternatives, human platelet lysate or human serum (Wolbank
et al., 2010), or even to find serum-free media compositions
(Evron et al., 2011; Pratama et al., 2011; Niknejad et al.,
2013). hAEC are described to proliferate robustly and display
typical cuboidal epithelial morphology between passage 2 and
6 before proliferation ceases (Terada et al., 2000; Ochsenbein-
Kölble et al., 2003; Miki et al., 2005) and do not proliferate
well at low densities (Parolini et al., 2008). hAEC in culture
have been reported to undergo morphological changes from
epithelial to fibroblast-like appearance (Portmann-Lanz et al.,
2006; Bilic et al., 2008; Stadler et al., 2008; Pratama et al.,
2011). These changes are most likely due to epithelial to
mesenchymal transition being driven by autocrine transforming
growth factor (TGF) beta1 production (Alcaraz et al., 2013)
or by external addition of TGF beta1 (Roy et al., 2015).
Expansion of hAMSC is possible for at least 5 passages without
morphological alterations (Alviano et al., 2007; Bilic et al.,
2008; Stadler et al., 2008; Insausti et al., 2010; Lisi et al.,
2012). Some groups have even kept hAMSC in culture for 15
to 20 passages before reaching senescence (Tamagawa et al.,
2007; Manochantr et al., 2010). Moreover, first-trimester hAMSC
have been shown to proliferate better than third-trimester cells
(Portmann-Lanz et al., 2006).
Human Amniotic Membrane Epithelial Cells (hAEC)
The hAM epithelium is the cellular layer directed towards the
fetus and in touch with the AF (Figure 5). hAEC locate in
all subregions of the hAM, and hence can be subdivided at
least into human reflected amniotic membrane epithelial cells
(hRAEC) and human placental amniotic membrane epithelial
cells (hPAEC).
Generally, isolated primary hAEC are heterogeneous for
their expression of surface antigens and also show varying
differentiation capabilities (Centurione et al., 2018), indicating a
heterogeneous population [reviewed by Miki and Strom (2006)].
Adding to the heterogeneity is the fact that amnioblasts, derived
from the epiblast, may differentiate randomly in the course of
embryonic development, and may retain in some cases stem
cell properties [reviewed by Miki and Strom (2006)]. Cultured
hAEC have been reported to undergo morphological changes
from epithelial to fibroblast-like appearance (Portmann-Lanz
et al., 2006; Bilic et al., 2008; Stadler et al., 2008; Pratama
et al., 2011). These changes are most likely due to epithelial-
mesenchymal transition being driven by autocrine TGF beta-1
production (Alcaraz et al., 2013) or by external addition of
TGF beta-1 (Roy et al., 2015). Surface marker expression of
hAEC has been described to change during culture. Freshly
isolated hAEC are positive for CD29, CD49c, CD73, CD166,
and stage-specific embryonic antigen (SSEA)-4, TRA-1-60, TRA-
1-81 (Centurione et al., 2018), whereas CD13, CD44, CD49e,
CD54, CD90, and CD105 increase during the first few passages
(Miki et al., 2005; Bilic et al., 2008; Stadler et al., 2008).
Furthermore, hAEC at passages (P) 2-4 are positive for CD9,
CD10, CD24, CD49e, CD49f, CD140b, CD324 (E-cadherin),
CD338 (ABCG2), HLA-A,B,C, SSEA-3, and STRO-1 (Miki et al.,
2005; Miki and Strom, 2006; Bilic et al., 2008; Parolini et al.,
2008; Magatti et al., 2015; Roy et al., 2015). CD117 (c-kit)
and CCR4 (CC chemokine receptor) are demonstrated to be
either negative or expressed on a few cells at very low levels
(Miki and Strom, 2006; Banas et al., 2008; Bilic et al., 2008;
Miki, 2011).
hAEC express markers that are otherwise found exclusively
in undifferentiated embryonic stem cells, embryonic carcinoma,
and embryonic germ cells (Figure 5A), (Miki et al., 2010).
In contrast to embryonic stem cells, hAEC do not express
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FIGURE 5 | Structure of the human amniotic membrane. (A) Schematic representation of the structure of the human amniotic membrane and tissues underneath
(chorion laeve and capsular decidua). Human amniotic membrane epithelial cells (hAEC) form, for the most part, a monolayer facing the amniotic fluid. The basement
membrane underneath separates the epithelial layer from the avascular amniotic mesoderm including the compact layer devoid of cells in touch with the basement
membrane and the fibroblast layer below it containing human amniotic membrane mesenchymal stromal cells (hAMSC). Between amniotic membrane and the
vascular chorionic mesoderm there are slender, fluid filled clefts forming an intermediate spongy layer. A basement membrane separates chorionic mesoderm from
extravillous trophoblast (hCL-EVT) (embedded in self-secreted matrix-type fibrinoid) which is in touch with maternal capsular decidua (hCD). (B) Histological image of
human amniotic membrane stained with haematoxylin-eosin staining solution. Magnification: 40x. (C) Transmission electron microscopy image showing the
ultrastructure of hAEC belonging to the central region of hAM (left panel) or the peripheral region of hAM. Green arrows point at surface microvilli; pale blue arrows
point at nuclei; blue arrows point at the basement membrane below hAEC; red asterisks point at different types of granules; orange asterisks point at nucleoli; yellow
triangle points at extracellular matrix of the compact layer. Magnification: 3000x.
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telomerase, are not tumorigenic, and do not become aneuploid
(Miki et al., 2005). Octamer-binding transcription factor (Oct)-
4 belongs to the POU family of transcriptional regulators
and is a transcription factor for maintaining pluripotency
and the ability of self-renewal (Rosner et al., 1990; Schöler
et al., 1990; Pesce et al., 1998; Lee et al., 2006). Early in
development, undifferentiated epiblast cells are positive for
Oct-4 and at gastrulation, with stem cell differentiation, Oct-
4 is downregulated in somatic cells and only maintained in
primordial germ cells [(Pesce et al., 1998); reviewed by Niwa
et al. (2000)]. Miki and colleagues proposed that since most
of the freshly isolated hAEC express Oct-4, they retain the
pluripotency of the undifferentiated epiblast [reviewed by Miki
and Strom (2006)]. Interestingly, Oct3/4 appears expressed in
all the regions of hAM although at a higher level in the
reflected and peripheral regions (Centurione et al., 2018). Oct-
4 found in differentiated tissue remains a matter of debate, as
two splice variants, Oct-4A and Oct-4B exist. Oct-4A seems
to play a role for pluripotency, whereas Oct-4B could be non-
functional (Cauffman et al., 2006; Lee et al., 2006). SSEAs
are glycolipids that play a role in the compaction process of
embryogenesis (Gooi et al., 1981). Compared to term, cells
isolated from first trimester hAM express significantly higher
levels of cell surface markers TRA-1-60 and TRA-1-81 (Izumi
et al., 2009), while in the intact epithelial layer of hAM at term
only scattered cells are positive for TRA 1-60 and TRA-1-81,
and weakly positive for SSEA-4, and these are surrounded by
cells negative for stem cell markers. This may be an indication
for the existence of a stem cell “niche”, with a highly specific
microenvironment that helps to maintain the stem cell state
(Miki et al., 2010).
hAEC in different regions of the hAM may differ in their
functional status, such as metabolic and secretory activity
(Banerjee et al., 2015; Lemke et al., 2017; Banerjee et al., 2018);
however, in relation to surface markers no differences in CD324,
CD326, CD73, and SSEA-4 and TRA-1-60 expression have
been found (Centurione et al., 2018). Concerning mesenchymal
markers, hAEC of all hAM regions have shown absence
or poor expression of CD90, CD105, CD146, CD140b, and
CD49a.
Human Amniotic Membrane Mesenchymal Stromal
Cells (hAMSC)
Human amniotic membrane mesenchymal stromal cells
are embedded in the rich extracellular matrix of the hAM
(Figure 5) and after isolation they confirm the previously
reported MSC minimal criteria (Parolini et al., 2008).
Furthermore, staining of the intact hAM confirmed that
hAMSC lack markers associated with pluripotency, such as
TRA-1-60 and TRA-1-81 (Miki et al., 2010). However, the
pluripotency markers SSEA-3 and SSEA-4 were reported
to be positive (Kim et al., 2007). So far, no phenotype
differences have been described for hAMSC originating
from different hAM regions, namely the human reflected
amniotic membrane mesenchymal stromal cells (hRAMSC) and
human placental amniotic membrane mesenchymal stromal
cells (hPAMSC).
Human Chorion (Chorionic Membrane)
(hCM)
The chorionic membrane (hCM) represents the fetal component
of the placenta. Cells from the hCM are generally referred to
as human chorionic membrane cells (hCMC). It is formed by
extraembryonic mesoderm and the two layers of trophoblast
(syncytiotrophoblast and cytotrophoblast) that surround the
embryo and other membranes. The chorionic villi emerge
from the entire chorion during the first phases of embryonic
development leading to the formation of the primitive placenta,
whereas later on they reach the highest level of development
and branching in correspondence of the chorion frondosum
which rises from the chorionic plate (hCP) and which forms the
definitive placenta together with the basal part of the maternal
decidua. The rest of the chorion, where villi have turned atrophic,
becomes smooth and subtle, does not take part at the formation
of the placenta and is called chorion laeve (hCL).
Very early in pregnancy, the chorion of the human
placenta starts as a double layer of trophoblast with the
syncytiotrophoblast covering the early intervillous space and a
layer of cytotrophoblast (hCTB) in second row, proliferating,
differentiating and maintaining the syncytiotrophoblast (hSTB)
via syncytial fusion. At the end of the second week after
fertilization (day 12 p.c.) a new layer of extraembryonic
mesenchymal cells (hCMSC) develops and covers the
cytotrophoblast towards the embryonic side. Thus, the
mesenchymal cells are added as a new border to the original
blastocyst cavity without a specific epithelial coverage. At that
time of gestation, the amniotic sac is still very small and not in
contact with the chorion.
Since first development of placental villi takes place all over
the surface of the chorion, the chorion frondosum, i.e., the part of
the chorion where placental villi are found, is not restricted to a
specific part of the chorion. At this time of placental development,
the entire chorion is chorion frondosum and the placenta proper
develops as a ball-shaped organ. Only at the end of the first
trimester, with the onset of maternal blood flow into the placenta,
villous tissues at the abembryonic part of the chorion regress,
leading to a smooth chorion, the chorion laeve. The remaining
part of the chorion frondosum develops into the chorionic plate
covering the placenta proper towards the fetus until delivery.
Hence, with the beginning of the second trimester, the placenta
changes its shape towards a disk-shaped organ.
Human Chorionic Mesenchymal Stromal Cells
(hCMSC)
In literature, there are descriptions of the general features and
characteristics of mesenchymal cells from term chorion, not
differentiating between chorionic plate (hCP-MSC) and chorion
laeve (hCL-MSC). Therefore, this paragraph displays the general
features of chorionic mesenchymal stromal cells (hCMSC), not
differentiating between the two sites.
Several publications have dealt with various isolation methods
of placental mesenchymal stromal cells and the comparison
of these cells isolated from different placental sites, with the
intention to find the most suitable ones. Isolation techniques
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vary from explant methods (Konig et al., 2015; Wu et al.,
2018; Ma et al., 2019; Yi et al., 2020), enzymatic methods
(Soncini et al., 2007; Kim et al., 2011; Yamahara et al., 2014;
Kwon et al., 2016; Sardesai et al., 2017; Araújo et al., 2018;
Ventura Ferreira et al., 2018; Chen et al., 2019; Yi et al., 2020),
or the combination of both (Huang et al., 2019). Isolation
methods using a modified explant culture technique combined
with enzymatic treatment achieved higher cell yield and better
proliferative capacity than conventional explant cultures (Huang
et al., 2019). hCMSC confirm the already reported MSC
morphology, phenotype, and differentiation potential (Dominici
et al., 2006; Parolini et al., 2008).
Human Trophoblast (hTB)
During early development of the embryo, the very first cell lineage
of the human is formed. At around day four after fertilization, the
blastocyst develops from the morula by differentiation of a cell
layer, the human trophectoderm (hTED). This is the forerunner
of all trophoblast cells and layers throughout pregnancy. At
the time of implantation, around day 6-7 after fertilization,
trophectoderm cells in contact with the embryoblast attach
to the uterine epithelium. Cells in direct contact with the
epithelium fuse and generate the first trophoblast cell type,
the syncytiotrophoblast (hSTB) that penetrates through the
uterine epithelium. This first multinuclear primitive syncytium
is the first invasive placental component that expands into the
maternal compartment. The other trophoblast cells remain as
undifferentiated human mononuclear cytotrophoblast (hCTB)
cells, characterized by an epithelium-like phenotype with
cuboidal cell shape (Huppertz, 2008; James et al., 2012;
Knöfler et al., 2019).
Three weeks after fertilization placental villi are fully
developed. The hSTB has differentiated into the outermost cover
of placental villi, now serving as the epithelial layer in direct
contact with maternal blood. Below the hSTB, proliferative
hCTB make up the second epithelial layer of the placental
villi. The villous cytotrophoblast (hVCTB) maintains the hSTB
by continuous proliferation, differentiation and fusion with the
hSTB (Huppertz, 2008). With the further differentiation and
fusion processes of the hVCTB with the pre-existing syncytium
the outer multinuclear syncytiotrophoblast layer is maintained
(Aplin, 2010), providing the nutritional and oxygen uptake route
to the developing embryo and fetus, and secreting hormones to
maintain pregnancy, such as human chorionic gonadotrophin
(hCG) and placental lactogen (Aplin, 2010).
The syncytiotrophoblast is a multinucleated and polar layer
without lateral cell borders, not showing any proliferative
activity. The syncytiotrophoblast only has an apical membrane
facing maternal blood and a basal membrane in contact
to the underlying villous cytotrophoblasts (Figure 3). The
maintenance of this syncytial layer is completely dependent on
the fusion of villous cytotrophoblast cells throughout pregnancy
(Huppertz, 2008).
Trophoblastic cell columns at the tips of anchoring villi
attached to the maternal decidua give rise to extravillous
trophoblast (hEVT) cells. Proliferative proximal cell column
trophoblast (hpCCT) sitting on its basal lamina represents the
progenitor cell pool of differentiated hEVT. In the distal cell
column, the cells differentiate into non-proliferative distal cell
column trophoblast (hdCCT). Some of these cells undergo
polyploidization and senescence upon differentiation into hEVT
(Velicky et al., 2018). In general, the entire pool of extravillous
trophoblast is derived from the cell column trophoblast.
The cell column trophoblast undergoes a multi-step
differentiation process with epidermal growth factor receptor-
positive (EGFR+) hpCCT, characterized by high proliferative
activity. These cells further differentiate into non-proliferating
human leukocyte antigen G-positive (HLA-G+) hdCCT, ready
to invade the decidua. HLA-G is expressed in all extravillous
trophoblast (King et al., 1996). EGFR is expressed by hVCTB and
proliferative hpCCT, but absent from hEVT, which specifically
up-regulates ERBB2 (Fock et al., 2015).
hEVT can be found at various sites of the feto-maternal
interface, such as the chorion laeve, the chorionic plate, cell
islands within the villous tissues, and in the uterus at the
site of the placental bed. Most of these cells invade into
the maternal uterine stroma and the inner third of the
myometrium as interstitial extravillous trophoblast (hiEVT)
(Huppertz, 2019). From the interstitial subtype of hEVT a
number of further subtypes develop and invade into all
luminal structures of the placental bed: endovascular extravillous
trophoblast (hvasEVT) invades into all maternal vessels of the
placental bed in the uterus. They can be further subdivided into
trophoblast cells invading into arteries, endoarterial extravillous
trophoblasts (hartEVT) and trophoblasts invading into uterine
veins, endovenous extravillous trophoblast (hvenEVT) (Moser
et al., 2017). Interstitial trophoblast also further invades
into uterine glands as endoglandular extravillous trophoblast
(hglaEVT) and into uterine lymph vessels as endolymphatic
extravillous trophoblast (hlymEVT), (Moser et al., 2010, 2015,
2017, 2018a; Windsperger et al., 2017). The invasion of hiEVT
is limited and is halted after reaching the inner third of the
myometrium. In the course of gestation hiEVT differentiates
from invasive cells into large polyploid cells or fuses to generate
multinucleated trophoblast giant cells.
Trophoblast stem cells (hTSC) are the progenitors of the
differentiated hCTB in the placenta. They have been isolated
from both the chorionic membrane and villous tissue of the
placenta [reviewed by Gamage et al. (2016)]. The sources of
hTSC or trophoblast progenitor cells (hTPC) are the blastocyst
and early first trimester placental tissue. Only recently in vitro
studies succeeded in deriving hTSC from blastocysts and primary
hCTB preparations (Okae et al., 2018), as well as from first
trimester placentas using 3D organoid cultures (Haider et al.,
2018; Turco et al., 2018; Sheridan et al., 2020). A reason for past
failures is the lack of suitable culture conditions (Nursalim et al.,
2020), promoting human trophoblast self-renewal and ongoing
in vitro proliferation of trophoblast cells after isolation from the
human placenta. Thus, characteristic stem cell markers for each
trophoblast subpopulation have been identified to overcome this
problem, such as CDX2 (Caudal Type Homeobox 2), which is
abundantly expressed in early first trimester, but becomes rapidly
downregulated and restricted to individual hVCTB towards the
end of the first trimester (Horii et al., 2016; Soncin et al., 2018).
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TEA Domain Transcription Factor 4 (TEAD4), E74 like
ETS Transcription Factor 5 (ELF5) and transformation-related
protein 63 (TP63) are expressed among the hVCTB population
of the first trimester human placenta. Transcription Factor AP-
2 Gamma (TFAP2C) and GATA Binding Protein 3 (GATA3)
are widely expressed across all trophoblast cell types (Lee et al.,
2016). Molbay et al., revealed that hTPC isolated from term
placenta were positive for the trophoblast stem cell markers
CDX2 and Eomesodermin (EOMES) in 92.5% and 92.7% of cells,
respectively (Molbay et al., 2018). Interestingly, the investigation
of vascular endothelial growth factor (VEGF), VEGF-Receptor
1 (R1), and VEGF-Receptor 2 (R2) at protein and mRNA
levels in comparison with human umbilical vein endothelial cells
(HUVEC), revealed that hTPC have higher levels of VEGF and
VEGFR1 transcripts (Molbay et al., 2018). Soluble forms of VEGF
and VEGFR1 were detected in supernatants of hTPC. In 2016,
Genbacev et al., suggested that integrin alpha 4 (ITGA4) was
the highest expressed factor in trophoblast stem/progenitor cells
isolated from term placenta (Genbacev et al., 2016). Therefore, a
high level of ITGA4 expression on the surface of the cells may be
used to identify hTPC from term placental tissues.
Interestingly, a recent study used trophoblast organoids
to generate hTSC (Sheridan et al., 2020). They demonstrate
that they can be established within 2-3 weeks, passaged every
7–10 days, and cultured up to one year. Importantly, the
authors found that hTSC resembled the villous placenta in
their transcriptomes and production of placental hormones.
Another group demonstrated that TSC can be isolated from
mice using anti-CD117 micro-beads from embryonic day 18.5
mouse placentas (Hou et al., 2020). Furthermore, as mentioned
above, the isolation of hTSC from blastocysts has previously
been demonstrated (Okae et al., 2018), while others have shown
that naïve human pluripotent stem cells (hPSCs) can be used to
establish hTSC (Dong et al., 2020).
Human Chorionic Plate (hCP)
The chorionic plate (hCP) of the human placenta is built up of
layers of two different origins, chorion and amnion. The amnion
is located towards the fetus and towards the intervillous space
the chorion frondosum is found, from which placental villi grow
into the trophoblast lacunae. Also, within the chorionic plate the
amniotic membrane is an avascular tissue.
The chorion frondosum differs from the chorion laeve in a
variety of aspects. It is a spongy layer with few mesenchymal
cells and clefts in direct contact with the amniotic membrane.
This layer is followed by a thicker layer of compact mesenchyme,
in which the chorionic plate blood vessels from the fetus to
the placenta (and vice versa) are located. This layer ends with
a rudimentary basement membrane towards the intervillous
space. At this site, remnants of the complete layering of the
chorion early in pregnancy can be found, including small
parts of the syncytiotrophoblast and nests or single extravillous
trophoblast cells. Since the cytotrophoblast cells are located
outside the villous part of the placenta, they are termed
extravillous trophoblast. Also, throughout pregnancy more and
more fibrinoid covers the surface of the chorionic plate in direct
contact with maternal blood.
Human Chorionic Plate Cells (hCPC)
The cells that are located in the chorionic plate belong to the
amnio-chorionic membrane as well as to the chorion frondosum
(Figure 6A). The cells of the amniotic membrane are described
elsewhere in the text, while the cells of the chorion frondosum
are described here. They include stromal mesenchymal cells,
vessel-related mesenchymal cells and endothelial cells as well as
extravillous trophoblasts.
Human Chorionic Plate Mesenchymal Stromal Cells
(hCP-MSC)
Some studies describe that hCP-MSC are devoid of maternally
derived MSC in contrast to villus-derived MSC and decidua-
derived MSC (Wu et al., 2018; Huang et al., 2019). However,
several research groups have observed that in vitro cell culture
passaging of MSC isolated from the chorionic plate and chorionic
villi led to a high risk of overgrowth by maternal MSC of the
placental decidua (Soncini et al., 2007; Sardesai et al., 2017).
This discrepancy could be explained by the use of different
isolation methods and cell culture media. Sardesi et al., showed
that chorion-derived MSC cultures rapidly became composed
entirely of maternal cells when they were cultured in the
standard culture medium with serum as fetal MSC did not
grow readily under these conditions in contrast to maternal
MSC (Sardesai et al., 2017). The authors focused on two key
parameters to keep the fetal chorionic MSC culture-free of
maternal cells: (1) a careful dissection of fetal tissue from
the central cotyledonary core that helps remove the majority
of maternal cells during isolation, (2) culture of the fetal
chorionic MSC in endothelial growth medium that propagates
their proliferative activity and suppresses maternal overgrowth.
In line with this, Huang et al., reported that MSC serum free
media did not completely prevent maternal contamination when
compared to endothelial growth medium supplemented with
serum (Huang et al., 2019). Interestingly, hAMSC cultured in
endothelial growth medium have a strikingly higher proliferative
activity than those cultured in standard medium with serum
(Konig et al., 2012).
Human chorionic plate mesenchymal stromal cells express
typical MSC markers (Dominici et al., 2006) and a few studies
have reported the expression of pluripotency related markers,
such as SOX2 and SSEA4, Oct-4 and Nanog, but this is
controversially discussed (Cauffman et al., 2006; Lee et al.,
2006; Liedtke et al., 2007, 2008). Interestingly, hCP-MSC also
express HLA-G, implicated in their immunomodulatory effects
and show higher CD106 expression compared to MSC derived
from umbilical cord, amnion, and decidua parietalis (Kim et al.,
2011; Wu et al., 2018).
Human Chorionic Plate Mesenchymal Stromal Cells
Derived From Blood Vessels (hCP-MSC-bv)
Human chorionic plate mesenchymal stromal cells derived from
blood vessels were isolated as explant cultures from blood
vessels of the chorionic plate and cultured in endothelial growth
medium (Konig et al., 2015). hCP-MSC-bv seem to support
angiogenesis to a higher extent than hAMSC, although both
cell types express a very similar MSC surface marker profile
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(Dominici et al., 2006; Parolini et al., 2008). In addition, both
cell types are positive for CD49a, and negative for alkaline
phosphatase (AP), and mesenchymal stem-cell like antigen-
1 (MSCA-1), smooth muscle actin (smA), desmin and von
Willebrand Factor (vWf).
Human Chorionic Plate Extravillous Trophoblast
(hCP-EVT)
Since the cytotrophoblast cells at the surface of the chorionic
plate are not located within villous tissues, they are, by definition,
extravillous trophoblast cells. They are the remnants of the
complete cytotrophoblast layer of the chorion frondosum early
in pregnancy. The extravillous trophoblasts of the chorionic
plate (hCP-EVT) display a round to polygonal phenotype with
hyperchromatic nuclei showing irregular shapes. Although in
general the hCP-EVT display the same phenotypic characteristics
as the hEVT in the decidua, they are generally smaller and
show less variation in their size and shape. They are HLA-
G positive and do not display any signs of proliferation,
migration or invasion.
Human Chorionic Villi (hCV)
In the human placenta, the chorionic villi are arranged as villous
trees that are connected via a major trunk to the chorionic plate.
From the major trunk, a stem villus, multiple branches develop
into intermediate villi, finally ending in free-floating terminal villi
(Figure 6B).
All chorionic villi of the human placenta share the
same general morphological structure. They have a core of
mesenchymal cells derived from extra-embryonic mesoderm.
The core structure of all villi contains vessels from large arteries
and veins in stem villi down to arterioles and venules in
intermediate villi and capillaries and sinusoids in terminal villi.
The extracellular matrix is composed of a large number of
reticular and collagen fibers.
The vessels are surrounded by MSC that show different levels
of differentiation from terminal to stem villi. Also, macrophages
(positive for markers such as CD68 and CD163) can be found in
the villous stroma of chorionic villi. These macrophages, referred
to as Hofbauer cells, are derived from two different sources,
directly developing from placental mesenchymal cells in the
villous stroma or deriving from circulating fetal monocytes.
The outer cover of the chorionic villi is organized as
a two-layered epithelium. The inner layer is composed of
mononucleated villous cytotrophoblast (hVCTB) cells that rest
on a basement membrane separating the trophoblast cells from
the villous stroma. The hVCTB cells proliferate and their
daughter cells differentiate to finally fuse with the overlying cover,
the hSTB, that is a true syncytium that comes into direct contact
with maternal blood circulating around the chorionic villi.
Human Chorionic Villi Cells (hCVC)
Within chorionic villi, fetal cells build the epithelial layer as
well as the villous core of the villi. The surrounding epithelium
is built by a continuous layer of syncytiotrophoblast, in direct
contact with the maternal blood, and an underlying layer
of mononucleated villous cytotrophoblast. Separated by the
FIGURE 6 | Cell populations from chorionic plate and chorionic villi.
Histological images of human chorionic plate (hCP) and chorionic villi (hCV).
Haematoxylin-eosin staining. (A) At low magnification (10x) the structure of
hCP and hCV is appreciable. hCP-MSC: human chorionic plate mesenchymal
stromal cells; hCP-EC: human chorionic plate endothelial cells. (B,C) At higher
magnification (20x) cell populations present in the chorionic villi are more
appreciable. hCVC, human chorionic villi cells; hCV-EC, human chorionic villi
endothelial cells: hCV-MSC, human chorionic villi mesenchymal stromal cells;
hCV-TC, human chorionic villi trophoblast cells.
trophoblastic basement membrane the villous stroma is filled
with mesenchymal cells, macrophages, and vessels formed by
endothelial cells, pericytes and smooth muscle cells.
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Human Chorionic Villi Mesenchymal Stromal Cells
(hCV-MSC)
MSC of the chorionic villi express MSC markers (Karlsson
et al., 2012; Abomaray et al., 2015; Lankford et al., 2015) in
accordance with established minimal criteria (Dominici et al.,
2006; Parolini et al., 2008). One study also demonstrated the
expression of embryonic stem cell markers such as TRA-
1-61, TRA-1-80 and SSEA-4 (Yen et al., 2005), although
as mentioned previously the expression of pluripotency
markers by MSC is widely debated. hCV-MSC differentiate
within the maturation of the growing villous tree (Benirschke
et al., 2006). This differentiation starts with MSC (vimentin
positive) and continues with MSC and reticulum cells
(vimentin and desmin positive) and fibroblasts (vimentin,
desmin and alpha smooth muscle actin positive), and
finally to myofibroblasts (vimentin, desmin, alpha smooth
muscle actin and gamma smooth muscle actin positive),
(Benirschke et al., 2006).
Human Chorionic Villi Trophoblast Cells (hCV-TC)
The villous trophoblast as a tissue can be divided into two
types of cells/layers: mononucleated cytotrophoblasts and the
multinucleated syncytiotrophoblast. It needs to be stressed here
that in a given placenta, there is only one syncytiotrophoblast
covering all chorionic villi of that placenta (Figure 6C).
Villous cytotrophoblast
The layer of the mononucleated villous cytotrophoblast is
the basal and germinative layer of the villous trophoblast
compartment. The cells rest on the basement membrane
underneath the villous trophoblast layers. Villous cytotrophoblast
cells change their morphology during pregnancy. During the
first trimester of pregnancy, the cells display a cuboidal
shape and form a nearly complete layer. At term, the
cells display a flattened phenotype, separated from each
other but connected to each other by long cytoplasmic
extensions. A subset of the cells proliferates throughout
pregnancy, which may point to a small subset of progenitor
cells within this layer. Also, some of the cells may display
their progenitor status as it has been shown that they can
be induced to differentiate towards the extravillous lineage
(Baczyk et al., 2009).
Villous syncytiotrophoblast
The syncytiotrophoblast is a continuous, multinucleated layer
without lateral cell borders. Hence, a single syncytiotrophoblast
covers all villi of a single placenta. The apical membrane of
the highly polarized syncytiotrophoblast shows microvilli
to amplify seven-fold the surface (Burton and Fowden,
2015) for a better uptake of nutrients from maternal blood.
As the syncytiotrophoblast is highly differentiated, growth
and maintenance of this layer is dependent on continuous
fusion with the underlying cytotrophoblast. The absence
of expression of class I or II major histocompatibility
complex proteins in the apical membrane of the
syncytiotrophoblast is important for its immunological
protection (Moffett and Loke, 2006).
Human Chorion Laeve (Chorionic Laeve
Membrane) (hCL)
The chorion laeve of the human placenta (hCL, Figure 7A)
develops at the end of the first trimester when the ball-
shaped placenta develops into a disk-shaped organ. The parts
of the early chorion frondosum that are not integrated into
the newly developing disk-shaped placenta show degeneration
of their placental villi, resulting in the smoothing of this
part of the chorion. This is why the chorion laeve is also
termed smooth chorion, or fetal membrane. As the amniotic
membrane develops into a layer covering the whole placenta, the
chorion laeve also contains the amniotic membrane as a cover
towards the fetus.
The chorionic part of the chorion laeve is organized into a thin
compact stromal layer, densely packed with collagen fibers and
containing only few scattered mesenchymal cells, and a fibroblast
layer with mesenchymal stromal cells (hCL-MSC, Figure 7B)
including fibroblasts and fewer myofibroblasts and macrophages.
The chorionic layer of the chorion laeve ends with a basement
membrane that separates the mesenchyme from the extravillous
trophoblast of the chorion laeve (hCL-EVT). The hCL-EVT layer
does not show signs of proliferation, but only displays fully
differentiated extravillous trophoblastst in a term placenta. At
some sites and at the end of pregnancy, atrophic villi can be
detected from the time of villous degeneration. Their stroma can
still be intact while vessels are missing. Such “ghost” villi are
surrounded by hCL-EVT.
Towards the uterus in touch with the chorion laeve is the only
maternal layer of this part of the placenta, the capsular decidua
(hCD). This layer includes decidual cells as well as some smaller
vessels plus mobile cells such as macrophages and lymphocytes.
It needs to be stressed that at the time of delivery the capsular
decidua or decidua capsularis is firmly attached to the parietal
decidua or decidua parietalis and, hence, some parts of the
decidua parietalis may be associated with the decidual layer of
the chorion laeve after delivery.
Human Chorion Laeve Mesenchymal Stromal Cells
(hCL-MSC)
Human chorion laeve mesenchymal stromal cells are plastic
adherent cells that follow the minimal phenotype and
differentiation criteria of the consensus paper by Parolini
et al., (Parolini et al., 2008). In addition, one study also suggested
that hCL-MSC can differentiate in vitro into cardiomyocytes and
express genes associated with heart morphogenesis and blood
circulation including serotonin receptor B2 (HTR2B) (Kwon
et al., 2016). hCL-MSC also display strong immunomodulatory
properties (Chen et al., 2019).
Human chorion laeve mesenchymal stromal cells have also
been shown to secrete cytokines quite common to MSC,
such as Insulin Growth Factor-1 (IGF-1), VEGF, Hepatocyte
growth factor (HGF), basic fibroblast growth factor (bFGF),
Angiopoietin 1 (Ang-1), and TGF, with partly contradictory data
about lower or higher secreted levels compared to hMSC derived
from amnion, umbilical cord, chorionic villi or decidua parietalis
(Yamahara et al., 2014; Yi et al., 2020).
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FIGURE 7 | Structure of the chorion laeve. Histological images of human amnio-chorionic membrane (hACM) in correspondence of the chorion laeve (hCL) and the
capsular decidua (hCD). Haematoxylin-eosin staining. (A) At low magnification (20x) a general overview of this portion of the amnio-chorionic membrane, which has
a smooth appearance due to the absence of chorionic villi, is appreciable. (B) At higher magnification (40x) it is possible to appreciate more cell populations present
in the chorion laeve including extravillous trophoblast (hCL-EVT) and mesenchymal stromal cells (hCL-MSC).
Human Chorion Laeve Extravillous Trophoblast Cells
(hCL-EVT)
The extravillous trophoblast of the chorion laeve (hCL-EVT)
displays a round to polygonal phenotype and irregularly
formed nuclei that are hyperchromatic. Also, the hCL-EVT
cells are generally smaller than the hEVT in the placental bed.
Interestingly, although hCL-EVT are HLA-G positive, they do
not show signs of invasiveness, different to their counterparts in
the placental bed. It has been speculated that local factors keep
these cells in a non-invasive state. Isolation of hCL-EVT has been
performed and published (Gaus et al., 1997).
Human Umbilical Cord (hUC)
In placental mammals, the umbilical cord (UC) (also called
funiculus umbilicalis) is a conduit that connects the placenta
to the developing embryo/fetus and is responsible for exchange
of nutrients and gasses during gestation. The human umbilical
cord is formed when the body stalk (including allantois) and
the vitelline duct (also called ductus omphalo-entericus) deriving
from the yolk sac plus the umbilical coelom are enveloped
by the spreading amnion between the fourth and the eighth
week. During the third month of gestation, numerous elements
degenerate: the vitelline duct (it can remain in the form of a
Meckel’s diverticulum); the allantois (it is obliterated to form the
median umbilical ligament); the vitelline circulation system in the
extra-embryonic region; the umbilical coelom, which clumps and
disappears. In humans, the umbilical cord is approximately 50 cm
long and 2 cm in diameter at term and is normally attached in the
middle of the placenta.
As shown in Figure 8A the structure shows an outer layer of
amniotic membrane (human umbilical cord amniotic membrane,
hUC-AM) that surrounds a mucoid connective tissue called
“Wharton’s jelly” (human umbilical cord Wharton’s jelly, hUC-
WJ), (Figure 8B), as Thomas Wharton described it for the
first time in 1656. This gelatinous and elastic connective tissue
is full of mesenchymal stem/stromal cells (human umbilical
cord vascular region, hUC-V) and generally contains three
vessels in humans, one vein and two arteries, which carry
oxygenated and deoxygenated blood between the placenta and
the fetus, respectively. Unlike other vessels of similar diameter,
the umbilical vessels display only a tunica intima and media
but are devoid of a tunica adventitia (Davies et al., 2017).
Currently, the roles of the tunica adventitia (vascular support
and some contractile function) are considered to be fulfilled by
the “Wharton’s jelly,” which also protects the umbilical vessels
from possible mechanical pressure and creasing. The jelly does
not contain other blood or lymph vessels and is devoid of nerve
supply. The absence of adventitia and other vessels, besides
the two arteries and one vein, is not typical of animal models
commonly used in research. This should be taken into account
when the same methods to extract cells from umbilical cords are
employed across species since variation in structure represents a
source of variability in the harvested cell population.
According to Mennan et al., 2013 the human umbilical cord
contains distinct anatomical regions comprising the vascular
region, cord lining, and Wharton’s jelly (Mennan et al., 2013).
Nanaev et al. (1997) identified three regions within the human
umbilical cord at term, based on the distribution of extracellular
matrix proteins and cytoskeletal features of the stromal cells:
the sub-amniotic zone, Wharton’s jelly and the combined
media and adventitia of the blood vessels (Nanaev et al.,
1997). Vieira Paladino et al. (2019) identified three different
regions inside Wharton’s jelly: sub-amniotic, intervascular and
perivascular regions (Vieira Paladino et al., 2019). Here we
propose the following umbilical cord regions and nomenclature
taking into account histological characteristics and embryological
development: human umbilical cord amniotic membrane (hUC-
AM, Figure 8A), corresponding to the cord lining of other
classifications, human umbilical cord Wharton’s jelly (hUC-WJ,
Figure 8B), including the sub-amniotic and intervascular regions
of other classifications, and human umbilical cord vascular region
(hUC-V), referred to cell populations present within the wall or
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FIGURE 8 | Structure and cell populations from the umbilical cord. (A) Schematic structure of the human umbilical cord showing the presence on the surface of the
amniotic membrane (hUC-AM) made of hUC-AEC and hUC-AMSC and the different regions of Wharton’s jelly (subamniotic, intermediate and perivascular).
hUC-WJ-MSC, human umbilical cord Wharton’s jelly mesenchymal stromal cells; hUC-PVC, human umbilical cord perivascular cells; hUC-V, human umbilical cord
vascular region; hUC-VSMC, human umbilical cord vascular smooth muscle cells. Histological images (Haematoxylin-eosin) of (B) hUC at low magnification (10x)
showing the presence of two umbilical arteries (light blue arrows) surrounded by human umbilical cord Wharton’s jelly (hUC-WJ), (C) umbilical artery at higher
magnification (20x) showing the presence of human umbilical cord perivascular cells (hUC-PV), (D) intermediate region of Wharton’s jelly showing at higher
magnification (40x) the presence of numerous mesenchymal stromal cells (hUC-iWJ-MSC).
in the perivascular region of umbilical vein and arteries contained
in the umbilical cord (Figures 8A,C).
Human Umbilical Cord Cells (hUCC)
The major cellular component derived from the umbilical cord
is composed of stromal cells that have a differing range of
differentiation potential from mesenchymal to myofibroblast
phenotype and can express various levels of cytoskeletal markers
such as vimentin, desmin, cytokeratin, and alpha smooth muscle
actin (Can and Balci, 2011; Conconi et al., 2011). Considering
this heterogeneity, hUCC located near the outer amniotic layer
are the most undifferentiated cells, sustaining the presence of
mesenchymal stromal cells in the amniotic fluid. Conversely,
hUCC close to the vascular zone are more differentiated stromal
cells and committed to myofibroblasts (Can and Balci, 2011;
Conconi et al., 2011). More recently, the connective tissue, in
which these stromal cells reside, has been hypothesized to consist
of three different anatomical regions - perivascular, intermediate,
and cord lining or sub-amniotic - with distinctive characteristics
and specific cellular populations (Davies et al., 2017).
Furthermore, stromal cells within the umbilical cord display
different characteristics depending on the region from which
they are derived. These peculiar features can be associated with
the fact that umbilical cord presents two different embryonic
origins: from the connection of stalk and allantoid mesenchyme
and from the covering of the amniotic membrane (Subramanian
et al., 2015). Furthermore, cell isolation methods are still not
standardized and due to the existence of two different approaches
(enzymatic and explant-based), there are various degrees of
variability for harvesting the cells from the umbilical cord. In
particular, enzymatic-based protocols are commonly used for the
isolation of hUCC by using collagenase, hyaluronidase, or other
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proteases. Differently, explant-based isolation procedures are
used because of higher cell yield and preserving cell membrane
protein integrity (Abbaszadeh et al., 2020).
Human Umbilical Cord Mesenchymal Stromal Cells
(hUC-MSC)
These cells are discussed under the paragraph of human umbilical
cord Wharton’s jelly cells because the connective tissue of the
umbilical cord is recognized as Wharton’s jelly (Davies et al.,
2017).
Human Umbilical Cord Amniotic Membrane Cells
(hUC-AMC)
The amniotic membrane lining of the umbilical cord represents
a possible source of two perinatal cell types: epithelial cells from
the epithelium of amniotic membrane and MSC from the stromal
side blended with the Wharton’s jelly (Lim and Phan, 2014).
Human Umbilical Cord Amniotic Epithelial Cells
(hUC-AEC)
The nature of the covering amniotic epithelium has not been
thoroughly investigated. Recent studies have demonstrated that
human umbilical cord amniotic epithelial cells (hUC-AEC) share
common features with fetal epidermal keratinocytes in terms
of the expression patterns of cytokeratins, cell surface markers,
and their differentiation potential (Ruetze et al., 2008). Umbilical
cord amniotic membrane cultured in modified keratinocyte
culture medium yields polyhedral epithelial cells and during
primary culture, hUC-AEC cells show a cobblestone appearance
characteristic of typical epithelial cells. The proliferation rate at
the beginning is relatively slow but then, after the initial clonal
growth, it becomes faster and gives rise to large and tightly packed
colonies (Lim and Phan, 2014).
Phenotype characterization of hUC-AEC has shown
expression of CK8, CD14, and CD19, markers associated to
simple epithelium and skin stem cells. Immunophenotype
analysis has shown that hUC-AEC are negative for CD45,
CD90, CD105, whereas they are positive for CD29, CD44,
CD49f, CD166. One study reported that a small fraction of
hUC-AEC display stem cell-specific molecules such as SSEA-4
and TRA-1-60 (Huang et al., 2011).
Human Umbilical Cord Amniotic Mesenchymal
Stromal Cells (hUC-AMSC)
Considering the embryological development of the umbilical
cord, the stromal component of the amniotic membrane is
completely fused with the connective part of the umbilical cord.
For this reason, it is difficult to distinguish and isolate a cell
population of amniotic origin with mesenchymal characteristics
(consider that during embryonic development the connective
tissue of the body stalk and the amniotic membrane form a
common umbilical cord connective tissue known as “Wharton’s
jelly,” for more details see Carlson (2013). However, several
authors have proposed that when amniotic membrane is cultured
in modified fibroblast media, spindle shaped fibroblast-like
mesenchymal cells can be obtained with plastic adherent
properties. Growing to confluence, these cell strains can form
colonies, a gross morphological indicator of stem cell identity
(Lim and Phan, 2014).
Human Umbilical Cord Wharton’s Jelly Cells
(hUC-WJC)
There is no consensus on the experimental protocols for isolation
of cells from Wharton’s jelly, nor on the anatomical structure of
the cord, and particularly that of the zones of Wharton’s Jelly,
from which the cells are extracted. As a matter of fact, it is
rarely possible to glean from published methods which cells are
specifically being cultured in experiments, or more importantly,
employed in clinical trials. Thus, there is an urgent need to arrive
at a consensus on the anatomical structure of the cord, and
particularly that of the zones of Wharton’s Jelly, from which the
cells are extracted.
Nonetheless, there is a current consensus that cells isolated
from Wharton’s jelly display MSC characteristics (Dominici
et al., 2006; Parolini et al., 2008). They can have two distinct
morphologies: flat, wide cytoplasmic cells, and slender fibroblast-
like cells (Karahuseyinoglu et al., 2007). These two cell
populations differ in their cytoskeletal filament content: vimentin
(mesenchymal marker) and pan-cytokeratin (ecto-endodermal
marker). As shown in Figure 8, the cell population positive
for both vimentin and pan-cytokeratin appears flattened and
is localized in the perivascular region (type I cell). The cell
population with a more fusiform and elongated (type II cell)
cytoplasm/morphology is positive only for vimentin, and it is
located in the intervascular region.
Human Umbilical Cord Wharton’s Jelly Mesenchymal
Stromal Cells (hUC-WJ-MSC)
Protocols for the isolation of hUC-WJ-MSC have not been
standardized. These cultures can be obtained either by enzymatic
digestion or by explant cultures, and both approaches have been
argued to be effective only when applied on fresh WJ tissue
(Davies et al., 2017).
Despite these limitations, Wharton’s jelly cells derived
from the human umbilical cord (hUC-WJC) also follow
the minimal phenotype and differentiation criteria of the
consensus paper by Parolini et al., (Parolini et al., 2008),
and express other mesenchymal common markers such as
CD10, CD13, CD29, CD44, CD54, CD73, CD90, CD105,
Stro-1, α-smooth muscle actin (αSMA), vimentin, MHC class
I molecules (classic HLA-A, -B, and –C, and non-classical
HLA-G, -E, and -F), and lack typical hematopoietic and
endothelial markers CD14, CD19, CD31, CD34, CD38, CD45
CD66b, CD80, CD86, CD106, CD133, and HLA-DR (Lee
et al., 2004; Moodley et al., 2009; Corrao et al., 2013;
Wang et al., 2018). The hUC-WJ-MSC immunophenotype
has usually been compared to mesenchymal cells derived
from adult sources but, in addition, there is some evidence
of pluripotent stem cell markers such as TRA-1-60, TRA-
1-81, SSEA-1, and SSEA-4 even if the expression levels are
significantly lower than in pluripotent cells and strictly depend
on isolation procedure and culture conditions (Fong et al., 2011;
Musiał-Wysocka et al., 2019).
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Human Umbilical Cord Sub-Amnion Wharton’s Jelly
Mesenchymal Stromal Cells (hUC-saWJ-MSC)
As mentioned above, the cord lining membrane mesenchymal
cells are fibroblast-like cells with spindle-shaped morphology
(Figure 8A) that meet the minimal criteria of perinatal MSC
(Parolini et al., 2008) for their typical adherence capacity and the
immunophenotype pattern (Lilyanna et al., 2013). hUC-saWJ-
MSC are positive for the mesenchymal cell markers as reported
in Parolini et al. (2008), moderately express the embryonic stem
cell marker SSEA-4, and they lack hematopoietic and endothelial
cell markers (Deuse et al., 2011).
Interestingly, hUC-saWJ-MSC can also display epithelial cell
properties due to the expression of cytokeratins CK1, CK7 and
CK14, the epithelial cell marker MUCIN1 (CD227), and the
epithelial cell-to-cell adhesion molecule CD151 (Kita et al., 2010;
Reza et al., 2011).
Human Umbilical Cord Intermediate Wharton’s Jelly
Mesenchymal Stromal Cells (hUC-iWJ-MSC)
For details on this cell population please refer to the cell
population described in the paragraph on hUC-WJ-MSC
(Figures 8A,D).
Human Umbilical Cord Perivascular Cells (hUC-PVC)
Almost 45% of the cells resident in the Wharton’s jelly reside in
the perivascular region (Figure 8C). Umbilical cord perivascular
cells have been shown to be positive for platelet derived growth
factor-receptor ß (PDGF- Rß) and CD146 (Avolio et al., 2017)and
NG2 (Montemurro et al., 2011). hUC-PVC are also positive for
MSC markers (Sarugaser et al., 2009; Lv et al., 2014) described
in the minimal consensus criteria (Dominici et al., 2006; Parolini
et al., 2008).
Human Umbilical Cord Vascular Smooth Muscle Cells
(hUC-VSMC)
Umbilical cord vessels can be considered a common source of
vascular smooth muscle cells (Figure 8A). Human umbilical
cord vascular smooth muscle cells (hUC-VSMC) can be obtained
either by enzymatic digestion or by explant cultures (Mazza
et al., 2016; Thormodsson et al., 2018). In vitro culture of human
umbilical cord vascular smooth muscle cells (hUC-VSMC)
promotes a switch from a contractile (quiescent) phenotype to a
more secretive (proliferating) one (Roffino et al., 2012). In many
previous studies, the characterization of primary hUC-VSMC has
been limited to the expression of the characteristic contractile
protein αSMA. Besides αSMA, hUC-VSMC have typical MSC
phenotype (Dominici et al., 2006; Parolini et al., 2008) and are
positive for smooth muscle myosin heavy chain (SM-MHC),
desmin, and vimentin. In contrast to human umbilical cord
perivascular cells (hUC-PVC), hUC-VSMC have been reported to
be negative for CD10 and display a high expression of SM-MHC
(Mazza et al., 2016).
Human Umbilical Cord Myofibroblasts (hUC-MF)
The differentiated myofibroblasts represent the functional
phenotype of Wharton’s jelly. Mesenchymal cells that comprise
the functional myofibroblasts of the stroma and their precursors
are found in this unusual connective tissue. These have a
fibroblast-like morphology and can be identified in five stages of
differentiation based on their sequential and additive expression
of vimentin, desmin, αSMA, γ-SMA, and smooth muscle myosin
(Nanaev et al., 1997; Davies et al., 2017).
Blood Vessels of the Human Term
Placenta and Umbilical Cord
As mentioned earlier, the umbilical cord comprises two fetal
arteries and one fetal vein. The umbilical arteries transport
low-oxygenated blood, loaded with metabolic waste products,
from the fetus via fetal arteries of the chorionic plate into
the placental villous tree, which mainly consists of (1) stem
villi with centrally located smaller arteries and veins, and
a paravascular capillary network; (2) intermediate villi with
arterioles, venules, capillaries; and (3) terminal villi with
sinusoids and capillaries. The intervillous space is filled with
maternal blood, supplied by afferent maternal spiral arteries
penetrating the basal plate and efferent maternal utero-placental
veins. The feto-maternal exchange takes place across the vasculo-
syncytial membrane of the terminal villi. There, the fetal
blood is loaded with oxygen and nutrients and transported
via the venous system of intermediate and stem villi, veins
of the chorionic plate and the umbilical vein back to the
fetus (Figure 1B).
Early in situ studies evidenced heterogeneity of the
endothelium of the umbilical cord and placental blood
vessels (Lang et al., 1993, 1994; Dye et al., 2001). Placental
fetal endothelium expresses CD32 and the transferrin receptor,
contrary to the endothelium of the umbilical cord and maternal
vessels, Bandeiraea simplicifolia (BS-I) lectin heterogeneously
stains placental and maternal vessels, but not umbilical
cord endothelium. Indoleamine 2, 3-dioxygenase 1 (IDO-
1) is absent in endothelial cells of the umbilical cord, but
present in endothelial cells of the human term placenta
(Blaschitz et al., 2011).
Endothelial cells have been mainly isolated by enzymatic
digestion from the human umbilical vein (HUVEC, Figure 9A),
to a smaller extent from umbilical arteries (HUAEC, Figure 9B)
and fetal placental vessels (hP-EC). They share typical endothelial
characteristics: they express vWF, which is stored in endothelial-
specific Weibel-Palade bodies, CD31, CD144, VEGF-R2 and can
be stained with Ulex europaeus I lectin that specifically binds
to L-fucose residues (Holthöfer et al., 1982; Hormia et al., 1983;
Hannah et al., 2002; van Mourik et al., 2002). They take up
acetylated low-density lipoprotein (acLDL) (Voyta et al., 1984),
form networks on Matrigel and lack expression of hematopoietic
markers like CD14, CD15, CD45, the mesenchymal stromal cell
marker CD90, and desmin, myosin, and smooth muscle actin.
Some endothelial markers change their expression pattern during
culture. Especially CD34, a most reliable endothelial marker
in situ, is only detectable in 20-30% of cultured endothelial cells
even in early passages (Müller et al., 2002).
HUVEC, HUAEC and hP-EC show differences in their
phenotype, genotype, functionality and DNA methylation profile
(Casanello et al., 2014) as summarized in the following sections.
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FIGURE 9 | Cells from blood vessels of human umbilical cord. Histological sections of human umbilical vein (A) and artery (B) at low magnification (20x).
Haematoxylin-eosin staining. hUC-MF, human umbilical cord myofibroblasts; HUAEC, human umbilical artery endothelial cells surrounding a lumen containing blood
cells; HUVEC, human umbilical vein endothelial cells surrounding an empty lumen.
Human Umbilical Vein Endothelial Cells (HUVEC) and
Human Umbilical Arterial Endothelial Cells (HUAEC)
Human umbilical vein endothelial cells HUVEC and HUAEC
have a cobblestone morphology in vitro. Specific transcription
factors, shear stress, and oxygen levels control the differential
expression of arterial- and venous-related genes (e.g., Hey2,
EphrinB2, NICD4 and COUP-transcription factor 2 (TF2),
respectively). HUAEC express higher levels of plasminogen
activator inhibitor-1 (PAI-1), Cx40, 17β-Hydroxysteroid
dehydrogenases (17β-HSD2), and vascular cell adhesion
molecule 1 (VCAM-1); and lower levels of vWF and estrogen
receptors β when compared to HUVEC. HUVEC and HUAEC
differ in their expression of angiotensin converting enzyme,
endothelin-1 and endothelial nitric oxide synthase (eNOS)
activity (Casanello et al., 2014).
Similar to hP-EC, HUVEC express CD31, CD34, CD105,
CD144, PAL-E, Tie-1, Tie-2, VEGF-R1, VEGFR-2 and HLA class
I molecules, but are negative for CD36 and CD133, contrary
to hP-EC (Sölder et al., 2012). HUVEC express lower levels of
angiotensin II, endothelin, and thromboxane, differ in homeobox
gene expression, and have a lower cholesterol transport capacity
and a lower proliferative response to cytokines when compared
to hP-EC (Casanello et al., 2014).
Human Placental Endothelial Cells (hP-EC)
Fetal hP-EC have no explicit nomenclature. This is partly caused
by different isolation methods, resulting in endothelial cell
cultures derived from various vascular regions, or the focus of
the respective manuscripts. According to Sölder and colleagues,
hP-EC grow either in cobblestone or in swirling pattern (Sölder
et al., 2012). They express vWF, UEA-1, HLA-class I, CD31,
CD34,CD36, CD51/61, CD54, CD62E, CD105, CD106, CD133,
CD141, CD143, CD144, CD146, VEGF-R1, VEGFR-2, EN-4,
PAL-E, BMA120, Tie-1, Tie-2, α-tubulin, but are negative for
VEGFR-3, LYVE-1, Prox-1, podoplanin, CD14, CD45, CD68,
HLA Class II. At the ultrastructural level, hP-EC harbor
numerous microvilli, micropinocytic vesicles at their basis, and
are rich in intermediate filaments.
Human Chorionic Villous Endothelial Cells (hCV-EC)
and Human Placenta Microvascular Endothelial Cells
(hP-mV-EC)
The terms hCV-EC and hP-mV-EC are often used synonymously,
although chorionic villi also comprise macrovascular endothelial
cells. Endothelial cells are obtained by enzymatic perfusion of
placental vessels (Schütz and Friedl, 1996; Jinga et al., 2000; Lang
et al., 2003; Murthi et al., 2007; Lang et al., 2008; Murthi et al.,
2008) or mechanical dissection followed by enzymatic digestion
and enclosed purification using immunomagnetic beads (Leach
et al., 1994; Wang et al., 2004a; Su et al., 2007; Escudero et al.,
2008; Sölder et al., 2012; Salomon et al., 2013; Troja et al., 2014;
Palatnik et al., 2016; Morley et al., 2018; Gao et al., 2020), or
they can be obtained from cultured microvessels after serial
sieving of placental villi and subsequent digestion of perivascular
cells (Challier et al., 1995; Kacémi et al., 1997). Enzymatic
perfusion of a placental lobule leads to endothelial cultures
enriched in microvascular endothelial cells (Lang et al., 2003;
Murthi et al., 2007; Murthi et al., 2008). Enzymatic perfusion
of the placental vasculature via the umbilical vein results in cell
preparations, which tend to originate from the venous system
of placental stem villi rather than from the microvasculature
(Schütz and Friedl, 1996; Jinga et al., 2000; Lang et al., 2003).
On the basis of the absent staining with BS-I lectin, several
authors suggested the microvascular origin of the isolated cells
(Schütz and Friedl, 1996; Jinga et al., 2000). However, deeper
in the chorionic villi, especially in intermediate and terminal
villi, which contain the major part of the microvasculature
(Kaufmann et al., 1985), the endothelium of blood vessels
becomes increasingly reactive with BS-I (Lang et al., 1994).
Thus, the cells isolated (Schütz and Friedl, 1996; Jinga et al.,
2000) may predominantly be derived from medium-sized veins
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of stem villi and by definition are not of ’microvascular origin’,
a terminology, which is restricted to arterioles, venules and
capillaries. These venous placental endothelial cells share some
similarities with microvascular placental endothelial cells like
spindle-shaped morphology, growth in swirling patterns, and
network formation at post-confluent state (Challier et al., 1995;
Kacémi et al., 1997). A recent study by Gao et al., revealed that
isolating clonal ECFCs from human early gestation chorionic
villi (CV-ECFCs) of the placenta by enzymatic digestion and
isolation by CD31-magnetic beads have the potential for fetal
tissue engineering (Gao et al., 2020).
Human Chorionic Plate Endothelial Cells (hCP-EC)
Enzymatic perfusion of chorionic arterial or venous blood vessel
segments leads to endothelial cultures of defined origin (Lang
et al., 2008). In vitro, human placental arterial endothelial
cells (hPA-EC) are polygonal cells with a smooth surface and
grow in loose arrangements and forming monolayers with
cobblestone morphology. They express artery-related genes (hey-
2, connexin 40, depp) and more endothelial-associated genes
than human placental venous endothelial cells (hPV-EC). VEGFs
induce a higher proliferative response on hPA-EC, whereas
placental growth factors (PlGFs) are only effective on hPV-
EC. In vitro, hPV-EC are spindle-shaped cells with numerous
microvilli at their surface. They grow closely apposed to
each other, form fibroblastoid swirling patterns at confluence
and have shorter generation and population doubling times
than hPA-EC. hPV-EC over-express development-associated
genes (gremlin, mesenchyme homeobox 2, stem cell protein
DSC54), and show an enhanced adipogenic and osteogenic
differentiation potential unlike hPA-EC (Lang et al., 2008).
These data provide evidence for a juvenile venous and
a more mature arterial phenotype of hCP-EC. The high
plasticity of hPV-EC may reflect their role as tissue-resident
endothelial progenitors during embryonic development with
a possible benefit for regenerative cell therapy (Lang et al.,
2008). A comparison of the genome-wide DNA methylation
profile in hPA-EC and hPV-EC show that venous endothelial
cells present lower levels of global methylation compared to
hPA-EC (Joo et al., 2013). hCP-EC were shown to express
IDO-1 unlike HUVEC (Blaschitz et al., 2011). The DNA
methylation status of NOS3 (eNOS) and ARG2 (arginase-2)
promoters by pyrosequencing suggest the presence of site-
specific differences between hPA-EC, HUAEC and HUVEC
(Casanello et al., 2014)
Human Amniotic Fluid (hAF)
From the second to the fourth week of gestation, the amniotic
fluid (hAF) gradually increases and separates the cells of the
epiblast (embryo) from the amnioblasts surrounding the embryo
in the newly formed amniotic cavity. The hAF allows for fetal
movements and growth inside the uterus. It also allows for the
exchange of different nutrients and chemicals between the fetus
and the mother (Fauza, 2004; Dobreva et al., 2010).
Human AF cells (hAFC) can be isolated during the three
trimesters of gestation (Di Trapani et al., 2015; Schiavo et al.,
2015; Spitzhorn et al., 2017), and have a heterogeneous origin
since they come from the urinary and pulmonary secretions of
the fetus, the skin, the digestive tract and the amniotic membrane
(Underwood et al., 2005) The phenotypic studies characterize the
cells into many shapes, from round to squamous, and different
sizes, ranging from 6 to 50 µm in diameter (De Coppi et al., 2009),
all of which grow in adhesion. It is conceivable that different
methods of hAF cell isolation give rise to cells with different
morphology. The “plastic adherence” is the most simple method
used to obtain cells from the hAF (Steigman and Fauza, 2007),
whereby fibroblast-like cells prevail. The “immunoselection”
method is based on the idea that the stem cell population within
hAF, that is present at a very low percentage, can be selected
using CD117 (or c-Kit) which is the most commonly used
antigen that identifies the hAF stem cell population referred to
as human amniotic fluid stem cells (hAFSC) (De Coppi et al.,
2007; Pozzobon et al., 2013). As described below, the capability
of this subpopulation to differentiate according to the different
in vitro and in vivo stimuli suggests their stem cell origin (Ditadi
et al., 2009; Piccoli et al., 2012). In 2004 a method based on “two
step culture” was also proposed where non-adherent cells from
the hAF are first seeded in media without serum, followed by a
second seeding in petri dishes (Tsai et al., 2004).
Human Amniotic Fluid Cells (hAFC)
Human amniotic fluid cells are a heterogeneous population
that can be classified into three groups according to their
molecular, morphological, and growth characteristics (Prusa and
Hengstschlager, 2002; Pipino et al., 2015): (1) epithelioid (E) type
cells, which originate from fetal skin and urine; (2) amniotic
fluid (AF) type cells which originate from the fetal membranes
and trophoblast; and (3) F type cells that originate from fibrous
connective tissues and dermal fibroblasts. Only the latter two
types (AF type and F type) have been shown to persist in in vitro
long-term culture. In addition, MSC from the AF (hAF-MSC)
have also been described.
Previous studies on hAFC detected cell markers from all
three germ layers (von Koskull, 1984; von Koskull et al., 1984;
Davydova et al., 2009) proved that a stem cell population
is present. Indeed, approximately 1% of the entire hAFC is
represented by the stem cell fraction named human amniotic
fluid stem cells (hAFSC), that can be clonally expanded by
selection with the surface antigen CD117 (De Coppi et al., 2007).
On one hand, hAFSC share many characteristics with
MSC such as the positivity for CD73, CD90, CD105, and
MHC class I, and lack of MHC class II, CD40, CD80, and
CD86 (Moorefield et al., 2011), with low immunogenic profile
(Di Trapani et al., 2013) according to gestational age (Di
Trapani et al., 2015). On the other hand, hAFSC express
pluripotency markers such as SSEA3, SSEA4, NANOG, KLF4
and MYC, TRA1-60 and TRA1-81 (Wolfrum et al., 2010;
Moschidou et al., 2013a,b; Zani et al., 2014), although they
do not form tumors when injected in mice (Chiavegato
et al., 2007; Moschidou et al., 2013b; Bertin et al., 2016).
The positivity for OCT-4 is still controversial. Maguire and
colleagues reported cytoplasmic and nuclear OCT-4 expression
by immunostaining, flow cytometry, clonal analysis, qPCR,
and dRNA-seq whole genomic profile (Maguire et al., 2013),
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on the contrary, a recent study demonstrated the opposite,
in particular for mid trimester hAFSC (Vlahova et al., 2019).
Nevertheless, hAFSC have been easily reprogrammed not only
with DNA-integrating systems (Wolfrum et al., 2010; Bertin
et al., 2016) but also without any genetic manipulation by
means of the histone deacetylase inhibitor, valproic acid (VPA)
(Moschidou et al., 2013a,b).
After CD117 selection hAFSC are either used directly
in vivo or grown in adhesion, and their natural environment
changes from a suspension fluid to a flat surface. Although
the antigen surface expression is detected at the first passages
(Di Trapani et al., 2013) and is gradually lost during
expansion, cell selection makes hAFSC a peculiar population
that maintains the ability to differentiate. Indeed, hAFSC can
differentiate toward the hematopoietic (Ditadi et al., 2009;
Loukogeorgakis et al., 2019), myogenic (Piccoli et al., 2012),
and endothelial cells (Schiavo et al., 2015), not only in vitro
but also in vivo and after secondary transplantation. In
an elegant work, Xinaris and colleagues performed chimeric
kidney organoids with hAFSC (after CD117 selection) and,
strikingly, human cells contributed to the formation of
glomerular structures, differentiating into podocytes (Xinaris
et al., 2016). Neuronal differentiation is still under investigation
and even if in vitro evidence on protein and function suggests
differentiation (De Coppi et al., 2007), it is still less clear
in vivo (Maraldi et al., 2014). Overall these properties distinguish
the stem cell population from the MSC present in AF (see
paragraph below).
Human Amniotic Fluid Mesenchymal Stromal Cells
(hAF-MSC)
Mesenchymal stromal cells from the amniotic fluid (hAF-MSC)
are plastic adherent cells defined following the minimal criteria
of the consensus paper by Parolini et al. (2008), Spitzhorn et al.
(2017). Accordingly, hAF-MSC differentiate toward adipogenic,
osteogenic and chondrogenic lineages (Spitzhorn et al., 2017).
Of note, the MSC fraction that originates from the hAF is still
identified by other surface markers that overlap with some of the
already cited proteins expressed by hAFC, such as SSEA4, TRA-
1-60, TRA-1-81 (Spitzhorn et al., 2017). hAF-MSC have also been
shown to be less prone to senescence with respect to other adult
sources of MSC such as bone marrow (Alessio et al., 2018).
Human Decidua (hD)
The decidua appears in mammals (including humans) with
hemochorial placentation and an invasive trophoblast. The
human decidua (hD) derives from the endometrium and is
therefore of maternal origin. After ovulation, during each
menstrual cycle, a reaction called decidualization develops. This
process of differentiation involves structural and functional
changes in all cells of the endometrium. If menstruation
occurs, this tissue is discarded; however, if pregnancy takes
place, decidualization continues through the effect of pregnancy
hormones (Moffett and Loke, 2006). Three types of hD
are distinguished, depending on the spatial relation to the
implanting embryo.
Human Basal Decidua or Decidua Basalis
Human basal decidua or decidua basalis (hBD) is located between
the myometrium and the chorionic plate. The basal decidua is a
thin plate of maternal endometrial tissue to which the anchoring
villi are attached and which is invaded by extravillous trophoblast.
The basal decidua modulates the allocation of maternal-fetal
resources. The vessels in the basal decidua supply maternal
arterial blood to the intervillous space between the fetal chorionic
villi and receive venous blood from the placenta (Benirschke
et al., 2012). Importantly, only the invasion of extravillous
trophoblast into decidual arteries and veins by endoarterial and
endovenous trophoblast cells, respectively, enables the proper
vascular flow through the placenta (Huppertz, 2019).
Human Capsular Decidua or Decidua Capsularis
Human capsular decidua or decidua capsularis (hCD) is the thin
layer of decidua that encapsulates the surface of the chorion
laeve towards the uterine lumen. With the growth of the fetus,
the capsular decidua is stretched and eventually fuses with
the parietal decidua, thereby obliterating the uterine cavity
(Benirschke et al., 2012).
Human Parietal Decidua or Decidua Parietalis
Human parietal decidua or decidua parietalis (hPD) is the
deciduous layer that covers the rest of the uterine cavity.
It contains maternal blood vessels and lymphatic vessels to
maintain the nutritional and metabolic balance in the maternal
compartment. From the third month of pregnancy, the hCD and
hPD merge together as a consequence of membrane and fluid
increment, as well as of fetal growth and development.
Histologically, the hD is composed of decidual stromal cells
(DSC, Figure 10), glandular epithelial cells, endothelial cells
and numerous leukocytes, with a predominance of large NK
CD56 bright cells (which decrease progressively in number
as pregnancy progresses), macrophages and T cells, and small
proportions of granulocytes and B cells (Yang et al., 2019).
Human Decidua Predecidual Stromal Cells
(hD-preDSC) and Human Decidualized Decidual
Stromal Cells (hD-dDSC)
Decidual stromal cells (DSC), the main cellular component
of the hD, exert activities that are thought to play a key
role in embryo implantation, trophoblast expansion, and the
development of fetal-maternal immune tolerance. These cells
originate from fibroblastic precursors located around the vessels
and are detected in both the endometrium and decidua. During
the luteal phase of the menstrual cycle, under the effect of the
ovarian hormones estradiol and progesterone (P4), a predecidual
reaction begins around the vessels and spreads through two thirds
of the endometrium facing the uterine cavity. Precursors of DSC
(preDSC) leave the vessels and differentiate into decidualized
cells, which exhibit a rounder shape and secrete prolactin (PRL)
and other factors such as insulin-like growth factor-binding
protein 1 (IGFBP1) and IL-15, and express dickkopf WNT
signaling pathway inhibitor 1 (DKK1), and forkhead box protein
O1 (FOXO1). When menstruation occurs, these differentiated
cells are discarded; however, if pregnancy takes place, this process
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FIGURE 10 | Decidua stromal cells. Histological images of human basal decidua (hBD). Haematoxylin-eosin staining. (A) A general overview of the uterine wall
containing human basal decidua decidualized stromal cells (hBD-dDSC) representing the maternal component of the human placenta facing the fetal component
represented by human chorionic villi (hCV) of the chorion frondosum is appreciable at low magnification (20x). (B) At higher magnification (40x) it is possible to
appreciate the cell populations present in the human decidua including hBD-dDSC.
of differentiation (decidualization) continues through the effect
of pregnancy hormones (Muñoz-Fernández et al., 2018; Vento-
Tormo et al., 2018).
There is a great deal of confusion in the terminology related to
DSC, but what must be considered is that in both the decidua
and endometrium, DSC can be found as undifferentiated and
differentiated (decidualized) cells; undifferentiated human DSC
are referred to as hD-preDSC (Olivares et al., 1997; Kyurkchiev
et al., 2010), and decidualized DSC are called hD-dDSC.
Decidual stromal cells can be obtained from first-trimester
decidua (elective termination of pregnancy) (Muñoz-Fernández
et al., 2018) or third-trimester decidua (cesarean delivery)
(Ringden et al., 2013). The isolation and maintenance of highly
purified human DSC lines in culture has made it possible
to study the antigen phenotype and activities of these cells.
DSC lines exhibit antigen phenotype and functional properties
equivalent to those of their corresponding fresh cells. The
maternal origin of DSC has been confirmed by microsatellite
polymorphism (Ringden et al., 2013; Muñoz-Fernández et al.,
2018). In the absence of P4, cAMP, and other decidualizing
factors in the culture medium, only hD-preDSC proliferate. In
first-trimester decidua, hD-preDSC express CD10 (endometrial
stromal cell marker), CD29, CD44, CD54, CD73, CD90, CD105,
CD140b, CD146, CD271, alpha SM actin, nestin, OCT3/4, SUS2,
podoplanin, STRO-1, and vimentin, and lack CD15, CD19,
CD31, CD34, CD45, CD62P, HLA-DR, and cytokeratin (Munoz-
Fernandez et al., 2012; Muñoz-Fernández et al., 2018; Vento-
Tormo et al., 2018).
Term placental DSC have been less studied than first trimester
DSC. In the parietal, capsular and basal decidua, hD-preDSC
(hPD-preDSC, hCD-preDSC, hBD-preDSC, respectively) show
a phenotype similar to that of the first trimester hD-preDSC
(Richards et al., 1995; Oliver et al., 1999; Ringden et al.,
2013; Ringden et al., 2018). Likewise, term hD-DSC are
decidualized in vitro in the presence of P4, as observed in the
case of basal (hBD-dDSC) and parietal (hPD-dDSC) human
decidualized decidual stromal cells by the secretion or expression
of PRL and IGFBP1 (Richards et al., 1995; Oliver et al.,
1999). In single cell RNA sequencing studies, term hBD-dDSC
have been identified that express the decidualization markers
DKK1, PRL, FOXO1, IGFBP1, and IL15 (Pavlicev et al., 2017;
Tsang et al., 2017).
Most data on DSC come from studies with hD-preDSC
cells from first trimester or term pregnancies, whereby cells
are isolated and cultured in a very similar manner: enzymatic
digestion (trypsin/EDTA) of decidual tissue followed by in vitro
culture in DMEM (Richards et al., 1995; Ringden et al.,
2013) or Opti-MEM (Muñoz-Fernández et al., 2018). The
main methodological difference was that some cultures were
in presence of 2%-3% serum (Richards et al., 1995; Muñoz-
Fernández et al., 2018) and others in 10% serum (Ringden et al.,
2013). The results regarding the antigen phenotype or functions
were, however, similar.
Human Decidua Mesenchymal Stromal Cells
(hDMSC)
Mesenchymal stromal cells that meet the minimal consensus
criteria (Dominici et al., 2006; Parolini et al., 2008) can be isolated
from first trimester and term hD (Choi et al., 2017). Furthermore,
hDMSC are negative for the costimulatory molecules CD40,
CD80, CD83 and CD86, and HLA-DR (Huang et al., 2009;
Dimitrov et al., 2010; Chen et al., 2015; Abomaray et al., 2016).
HLA typing analysis revealed that MSC isolated from the decidua
are of maternal origin (In ’t Anker et al., 2004). During the
isolation process, the decidual tissue is minced and then digested
using collagenase, trypsin or the combination of both. It has been
suggested that the collagenase-only protocol is best for hDMSC
isolation because of high cell recovery rate (Araújo et al., 2018);
but there is currently no study to determine the difference of
hDMSC isolated by different methods.
Most studies on hDMSC have been based on cells isolated
from the basal decidua (hBD-MSC) (Abomaray et al., 2016),
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although cells with similar characteristics have been obtained
from the parietal decidua in term placenta (hPD-MSC) (In ’t
Anker et al., 2004; Kanematsu et al., 2011; Castrechini et al., 2012;
Abumaree et al., 2016).
By retroviral transfer of reprogramming factor genes, hBD-
MSC have been reprogrammed into pluripotent stem cells
that maintain a normal karyotype, share similar characteristics
to human embryonic stem cells, and differentiate into the
three mesenchymal lineages (Shofuda et al., 2013). hPD-MSC
exhibit a typical fibroblast-like morphology and are able to
differentiate into adipocytes and chondrocytes but possess a
limited potential to differentiate into osteoblasts. Furthermore,
these cells were shown to secrete several growth factors and other
active molecules which bestow them with functional diversity
(Huang et al., 2010; Abumaree et al., 2016), especially concerning
their antitumor activity (Bahattab et al., 2019).
In addition, the expression of pericyte-associated antigens
such as 3G5, STRO-1, CD146 and αSMA suggested that hPD-
MSC may be derived from vascular stem cells (Castrechini et al.,
2012). Interestingly, hD-preDSC from first trimester and term
decidua also show similar characteristics to those of hDMSC:
antigen phenotype, clonogenic capacity, perivascular location,
and ability to differentiate into the mesenchymal lineages
(Richards et al., 1995; Dimitrov et al., 2010; Castrechini et al.,
2012; Muñoz-Fernández et al., 2018). Therefore, it is reasonable
to believe that hD-preDSC and the hDMSC described above
belong to the same cell population.
CONCLUSION
Herein we addressed a few major challenges in the field of
perinatal derivatives. First, we provide a thorough description
and mapping of the human placenta, including a description of
the different cell populations and clarification of where they are
located within perinatal tissues. Second, given that the names
and abbreviations used to refer to the different cell populations
are often misleading and even inappropriate, we propose
nomenclature for perinatal tissue and cells. Another important
challenge relates to cell isolation and culture/expansion because
specific characteristics, such as phenotype, change during culture
and can depend, in many cases, on culture conditions. The
literature analysis we performed did not allow us to identify
specific markers to uniquely identify the cell populations
discussed herein. At the current time, this is a quasi impossible
task due to the heterogeneity of the starting material given by
varying isolation and culture protocols. In addition, even though
there are a few reports claiming that perinatal cells express
markers that are not present in all perinatal regions, a detailed
comparison and confirmation by other research groups is needed.
A widespread comparison between isolation protocols, culture
conditions, and cell phenotype, remains a critical challenge to be
addressed. Therefore, we propose that consortiums active in the
field work together to address this challenge. We also propose
the adoption of the herein proposed nomenclature based on the
precise tissue and cell localization. A defined starting material is
the first step towards better data interpretation, study comparison
and ultimately, for the establishment of standard cell preparation
protocols for clinical use (Brooke et al., 2009; Kabagambe et al.,
2017; Lankford et al., 2017; Phinney and Galipeau, 2019; Aghayan
et al., 2020).
That having been said, a concerted effort is still required
to standardize perinatal cells. Even though the current
cell heterogeneity doesn’t seem to be a limiting factor for
functionality and therapeutic efficacy, since preclinical studies
and initial clinical trials have demonstrated efficacy of different
perinatal cells. Rather, standardizing cells and deciphering cell
heterogeneity is of utmost importance to potentially fine-tune
cells for specific therapeutic applications and to select cells that
will provide an optimal response to the disease.
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